Index S&P 500 P/E 15.14 EPS (ttm) 27.43 Insider Own 0.41% Shs Outstand 233.07M Perf Week -16.44%
Market Cap 96.30B Forward P/E 11.47 EPS next Y 36.22 Insider Trans -6.19% Shs Float 230.96M Perf Month -21.26%
Income 6.42B PEG 1.68 EPS next Q 4.56 Inst Own 91.51% Short Float 1.05% Perf Quarter -19.22%
Sales 174.01B P/S 0.55 EPS this Y 2.55% Inst Trans 1.05% Short Ratio 2.10 Perf Half Y -22.20%
Book/sh 188.74 P/B 2.20 EPS next Y 6.56% ROA 5.65% Short Interest 2.42M Perf Year -8.09%
Cash/sh - P/C - EPS next 5Y 9.01% ROE 15.62% 52W Range 397.98 - 567.26 Perf YTD -11.94%
Dividend Est. 6.35 (1.53%) P/FCF 110.57 EPS past 5Y 12.18% ROI 9.37% 52W High -26.80% Beta 0.82
Dividend TTM 6.37 (1.53%) Quick Ratio - Sales past 5Y 13.24% Gross Margin - 52W Low 4.34% ATR (14) 16.00
Dividend Ex-Date Dec 05, 2024 Current Ratio 1.50 EPS Y/Y TTM 7.55% Oper. Margin 5.29% RSI (14) 20.32 Volatility 4.96% 2.66%
Employees 104900 Debt/Eq 0.62 Sales Y/Y TTM 3.20% Profit Margin 3.69% Recom 1.70 Target Price 530.56
Option/Short Yes / Yes LT Debt/Eq 0.56 EPS Q/Q -20.03% Payout 23.47% Rel Volume 1.50 Prev Close 419.84
Sales Surprise 2.88% EPS Surprise -13.33% Sales Q/Q 5.36% Earnings Oct 17 BMO Avg Volume 1.15M Price 415.24
SMA20 -14.05% SMA50 -20.08% SMA200 -19.78% Trades
Volume 280,244 Change -1.10%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-18-24 Downgrade Argus
Buy → Hold
Jul-18-24 Downgrade BofA Securities
Buy → Neutral
$646 → $530
Jun-24-24 Initiated Morgan Stanley
Overweight
$643
May-30-24 Initiated Robert W. Baird
Outperform
$649
Mar-06-24 Initiated Barclays
Overweight
$584
Jul-12-23 Downgrade Wolfe Research
Outperform → Peer Perform
Apr-27-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$500 → $571
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$547
Mar-28-23 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$523 → $572
Sep-09-22 Upgrade BofA Securities
Neutral → Buy
$535 → $575
Aug-22-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$490 → $580
Show Previous Ratings
Today 10:00AM
Oct-19-24 07:00AM
(The Wall Street Journal)
Oct-18-24 04:59PM
12:57PM
03:02AM
01:06AM
Loading…
01:06AM
(Thomson Reuters StreetEvents)
01:02AM
12:00AM
(Associated Press Finance)
Oct-17-24 07:24PM
(Morningstar Research) -10.59%
07:17PM
07:17PM
05:10PM
03:33PM
03:04PM
(The Wall Street Journal)
01:56PM
01:45PM
Loading…
01:45PM
01:09PM
12:54PM
12:38PM
12:15PM
11:37AM
11:35AM
(The Wall Street Journal)
10:51AM
10:35AM
09:58AM
09:30AM
08:36AM
07:10AM
06:06AM
(Associated Press Finance)
06:00AM
12:10PM
Loading…
Oct-16-24 12:10PM
Oct-14-24 09:15AM
08:27AM
Oct-12-24 07:41AM
Oct-10-24 10:00AM
Oct-07-24 03:22PM
10:59AM
08:00AM
06:17AM
Oct-04-24 01:22PM
Oct-02-24 01:00PM
Sep-30-24 10:45AM
Sep-26-24 10:20AM
Sep-25-24 01:49PM
Sep-13-24 05:08AM
Sep-05-24 12:58PM
07:59AM
Aug-29-24 03:01AM
Aug-25-24 04:22PM
Aug-22-24 03:09PM
Aug-20-24 04:40PM
Aug-19-24 08:39AM
Aug-16-24 11:30AM
Aug-13-24 07:08PM
Aug-12-24 10:00AM
Aug-06-24 11:30PM
Aug-02-24 07:43AM
Jul-31-24 05:00PM
Jul-29-24 03:29PM
Jul-26-24 10:40PM
Jul-25-24 07:00AM
(The Wall Street Journal)
Jul-23-24 12:23AM
Jul-19-24 12:33PM
(The Wall Street Journal)
Jul-18-24 02:58AM
(Thomson Reuters StreetEvents)
01:01AM
Jul-17-24 01:33PM
12:00PM
10:52AM
10:42AM
10:16AM
(The Wall Street Journal)
10:02AM
(The Wall Street Journal)
09:30AM
07:10AM
06:18AM
06:17AM
(The Wall Street Journal)
06:06AM
(Associated Press Finance)
06:00AM
Jul-16-24 09:40AM
Jul-12-24 02:40PM
09:15AM
Jul-10-24 10:00AM
Jul-08-24 01:00PM
12:22PM
Jul-04-24 05:30AM
(The Wall Street Journal)
Jul-03-24 07:50AM
Jun-30-24 11:42AM
Jun-28-24 09:40AM
Jun-27-24 03:56PM
(Investor's Business Daily)
Jun-26-24 04:05PM
Jun-23-24 10:25AM
Jun-20-24 12:22PM
Jun-19-24 03:25PM
12:02PM
Jun-14-24 11:00AM
Jun-13-24 09:16PM
(The Wall Street Journal)
12:56PM
09:45AM
Jun-12-24 12:31PM
09:40AM
Jun-10-24 07:01AM
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Kendrick Charles Morgan JR EVP & President, Commercial Oct 18 '24 Sale 432.14 7,417 3,205,182 8,423 Oct 18 05:21 PM Kendrick Charles Morgan JR Director Oct 18 '24 Proposed Sale 432.28 7,417 3,206,221 Oct 18 01:48 PM PERU RAMIRO G Director Aug 05 '24 Sale 531.52 753 400,235 8,744 Aug 06 05:23 PM RAMIRO G PERU Director Aug 05 '24 Proposed Sale 531.52 753 400,235 Aug 05 04:14 PM BOUDREAUX GAIL President and CEO Jul 22 '24 Sale 500.98 34,000 17,033,395 126,709 Jul 23 05:02 PM Dixon Robert L JR Director Jul 19 '24 Sale 506.76 305 154,562 9,721 Jul 22 04:30 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Option Exercise 238.27 5,473 1,304,052 45,571 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Option Exercise 238.27 2,043 486,786 33,503 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 23 '24 Sale 533.74 14,111 7,531,565 31,460 Apr 25 05:05 PM Norwood Felicia F EVP & President,Gov Health Ben Apr 24 '24 Sale 532.44 6,199 3,300,590 27,304 Apr 25 05:05 PM Kendrick Charles Morgan JR EVP & President, Commercial Mar 08 '24 Sale 500.46 2,432 1,217,119 15,840 Mar 12 04:26 PM Penczek Ronald W CAO & Controller Mar 06 '24 Sale 504.58 916 462,195 1,764 Mar 08 04:16 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Option Exercise 166.97 15,000 2,504,550 39,982 Mar 05 04:24 PM Haytaian Peter D EVP & Pres Carelon & CarelonRx Mar 04 '24 Sale 500.18 21,095 10,551,297 18,887 Mar 05 04:24 PM PERU RAMIRO G Director Feb 07 '24 Sale 500.00 753 376,500 9,109 Feb 09 04:22 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Option Exercise 311.48 5,492 1,710,648 18,004 Dec 15 04:28 PM Todt Blair Williams EVP, CLO & CAO Dec 14 '23 Sale 484.02 5,492 2,658,238 12,512 Dec 15 04:28 PM Penczek Ronald W CAO & Controller Nov 30 '23 Sale 475.17 1,055 501,304 1,787 Dec 01 04:21 PM Penczek Ronald W CAO & Controller Oct 24 '23 Sale 454.35 64 29,078 2,842 Oct 26 04:15 PM
Index RUT P/E - EPS (ttm) -0.81 Insider Own 54.56% Shs Outstand 188.95M Perf Week -8.31%
Market Cap 2.07B Forward P/E - EPS next Y -0.50 Insider Trans -1.00% Shs Float 86.93M Perf Month -2.08%
Income -152.79M PEG - EPS next Q -0.14 Inst Own 41.05% Short Float 4.50% Perf Quarter 15.60%
Sales 2.23B P/S 0.93 EPS this Y 14.78% Inst Trans 5.36% Short Ratio 3.24 Perf Half Y 108.88%
Book/sh 0.65 P/B 16.73 EPS next Y 25.95% ROA -20.37% Short Interest 3.91M Perf Year 51.97%
Cash/sh - P/C - EPS next 5Y - ROE -91.58% 52W Range 4.46 - 12.36 Perf YTD 25.67%
Dividend Est. 1.24 (11.44% ) P/FCF - EPS past 5Y -35.06% ROI -44.46% 52W High -12.46% Beta 1.46
Dividend TTM - Quick Ratio - Sales past 5Y 24.61% Gross Margin - 52W Low 142.60% ATR (14) 0.74
Dividend Ex-Date - Current Ratio 1.61 EPS Y/Y TTM 8.96% Oper. Margin -5.88% RSI (14) 49.03 Volatility 7.06% 7.82%
Employees 1536 Debt/Eq 1.78 Sales Y/Y TTM 37.46% Profit Margin -6.85% Recom 2.00 Target Price 10.50
Option/Short Yes / Yes LT Debt/Eq 1.78 EPS Q/Q 17.83% Payout - Rel Volume 0.24 Prev Close 10.76
Sales Surprise 6.84% EPS Surprise 8.90% Sales Q/Q 47.34% Earnings Oct 29 AMC Avg Volume 1.21M Price 10.82
SMA20 -2.75% SMA50 4.00% SMA200 39.32% Trades
Volume 46,835 Change 0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-11-24 Initiated KeyBanc Capital Markets
Sector Weight
May-30-24 Upgrade BofA Securities
Neutral → Buy
$7.75 → $11
May-30-24 Initiated Robert W. Baird
Outperform
$10
May-08-24 Upgrade Piper Sandler
Neutral → Overweight
$6 → $8
Mar-06-24 Initiated Barclays
Underweight
$4.50
Mar-06-24 Downgrade Piper Sandler
Overweight → Neutral
$12 → $6
Jan-24-24 Initiated Stifel
Buy
$11
Nov-02-23 Downgrade BofA Securities
Buy → Neutral
$7.50 → $7.25
Oct-16-23 Upgrade Raymond James
Outperform → Strong Buy
$9 → $10
Oct-12-23 Initiated Stephens
Equal-Weight
$9
May-01-23 Upgrade Raymond James
Mkt Perform → Outperform
$9
Feb-23-23 Downgrade JP Morgan
Overweight → Neutral
$22 → $12
Nov-21-22 Downgrade Raymond James
Outperform → Mkt Perform
Sep-08-22 Resumed Piper Sandler
Overweight
$19
May-26-22 Upgrade BofA Securities
Neutral → Buy
$18 → $14
Dec-14-21 Initiated Goldman
Buy
$20
Dec-03-21 Initiated JP Morgan
Overweight
$20
Sep-10-21 Initiated Cowen
Outperform
$24
Aug-12-21 Initiated Barclays
Overweight
$25
Apr-20-21 Initiated William Blair
Outperform
Show Previous Ratings
Oct-22-24 10:01AM
Oct-18-24 08:00AM
Oct-11-24 08:00AM
Oct-03-24 11:00AM
08:21AM
08:11AM
Loading…
Oct-02-24 08:11AM
Oct-01-24 08:00AM
Sep-09-24 03:27PM
Sep-05-24 08:00AM
Aug-29-24 08:00AM
Aug-28-24 08:00AM
Aug-21-24 08:00AM
Aug-16-24 07:03PM
04:30PM
Aug-01-24 07:30PM
05:35PM
Loading…
05:35PM
04:35PM
(Associated Press Finance)
04:01PM
Jul-30-24 08:00AM
Jul-20-24 01:07AM
01:06AM
Jul-18-24 07:01PM
Jul-16-24 07:01PM
Jul-12-24 08:10AM
Jul-11-24 08:00AM
Jun-24-24 08:00AM
Jun-18-24 02:11AM
Jun-15-24 02:53AM
May-22-24 08:00AM
May-08-24 07:09AM
10:52AM
Loading…
May-04-24 10:52AM
May-03-24 11:30AM
08:21AM
(Thomson Reuters StreetEvents)
May-02-24 08:59PM
07:00PM
05:55PM
05:35PM
04:32PM
(Associated Press Finance)
04:01PM
Apr-30-24 08:00AM
Apr-25-24 10:01AM
Apr-11-24 08:00AM
Apr-02-24 08:00AM
Mar-21-24 07:02PM
07:01PM
Mar-16-24 01:49AM
Mar-07-24 04:30PM
Feb-29-24 05:38PM
(GlobeNewswire) +6.01%
-6.00%
Feb-28-24 09:32AM
08:19AM
(Thomson Reuters StreetEvents)
Feb-27-24 06:30PM
04:59PM
(Associated Press Finance)
04:46PM
04:01PM
Feb-26-24 09:15AM
Feb-20-24 10:00AM
Feb-06-24 08:00AM
Jan-09-24 08:00AM
07:39AM
Jan-08-24 08:00AM
Dec-19-23 08:00AM
Dec-01-23 08:00AM
Nov-29-23 09:43AM
Nov-05-23 03:02PM
Nov-02-23 07:00PM
06:57PM
04:26PM
(Associated Press Finance)
04:01PM
Oct-25-23 08:00AM
Oct-20-23 05:47PM
Oct-17-23 08:00AM
07:16AM
Oct-16-23 08:00AM
Oct-12-23 08:00AM
Oct-10-23 01:57PM
11:00AM
Oct-03-23 08:00AM
Oct-02-23 08:00AM
Sep-18-23 08:52AM
Sep-15-23 07:00PM
Sep-07-23 06:00AM
Sep-06-23 04:01PM
Aug-30-23 08:00AM
Aug-03-23 10:30PM
05:25PM
04:14PM
04:01PM
Jul-31-23 08:00AM
Jul-20-23 11:35AM
Jul-18-23 08:00AM
Jul-17-23 04:05PM
Jul-13-23 08:00AM
Jul-10-23 08:44AM
Jul-09-23 09:44AM
Jul-06-23 08:00AM
Jul-05-23 11:00AM
Jun-21-23 09:58AM
Jun-06-23 08:00AM
May-24-23 08:00AM
May-04-23 06:25PM
Alignment Healthcare, Inc. operates as a holding company. The company offers a consumer-centric platform that delivers customized health care solutions to seniors and those who need it most, the chronically ill and frail, through its Medicare Advantage plans. The firm offers health plan options through Alignment Health Plan, and partners with select health plans to help deliver better benefits at lower costs. The company was founded by John E. Kao in 2013 and is headquartered Orange, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Maroney Dawn Christine President, Markets Oct 15 '24 Sale 10.77 30,000 323,082 1,726,097 Oct 16 05:40 PM Freeman Robert Thomas Chief Financial Officer Oct 14 '24 Sale 11.50 30,500 350,872 164,109 Oct 16 05:37 PM FCO HOLDINGS LLC Officer Oct 14 '24 Proposed Sale 11.45 61,000 698,450 Oct 15 08:04 AM Kim Hyong Chief Medical Officer Oct 08 '24 Sale 11.03 22,460 247,734 533,070 Oct 10 06:58 PM KAO JOHN E Chief Executive Officer Oct 09 '24 Sale 11.33 90,000 1,019,538 2,543,100 Oct 10 06:57 PM Freeman Robert Thomas Chief Financial Officer Oct 08 '24 Sale 12.04 39,320 473,350 194,609 Oct 10 06:56 PM FCO HOLDINGS LLC Officer Oct 08 '24 Proposed Sale 10.85 37,820 410,347 Oct 08 04:23 PM Hyong Kim Officer Oct 08 '24 Proposed Sale 10.92 22,037 240,644 Oct 07 05:00 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Oct 01 '24 Sale 11.79 667 7,866 364,445 Oct 03 06:19 PM Freeman Robert Thomas Chief Financial Officer Oct 01 '24 Sale 10.66 21,375 227,824 243,054 Oct 03 06:17 PM Freeman Robert Thomas Chief Financial Officer Oct 02 '24 Sale 11.01 9,125 100,432 233,929 Oct 03 06:17 PM Warburg Pincus LLC Affiliate Sep 20 '24 Proposed Sale 11.39 4,300,000 48,977,000 Sep 20 06:39 PM Maroney Dawn Christine President, Markets Sep 16 '24 Sale 11.70 30,000 351,027 1,756,097 Sep 18 04:20 PM KONOWIECKI JOSEPH S Director Sep 17 '24 Sale 11.77 16,413 193,181 1,141,808 Sep 18 04:18 PM KAO JOHN E Chief Executive Officer Sep 16 '24 Sale 11.70 90,000 1,052,874 2,633,100 Sep 18 04:16 PM Joseph Konowiecki Director Sep 17 '24 Proposed Sale 11.89 15,690 186,554 Sep 16 07:04 PM DAWN MARONEY Officer Sep 16 '24 Proposed Sale 11.89 90,000 1,070,100 Sep 16 04:40 PM JEK TRUST U/A DTD 02/08/2021 Director Sep 16 '24 Proposed Sale 11.89 360,000 4,280,400 Sep 16 04:33 PM Kardes Hakan Chief Experience Officer Sep 12 '24 Sale 11.48 25,000 287,052 380,444 Sep 13 06:24 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 11 '24 Sale 9.61 34,626 332,925 365,112 Sep 13 06:22 PM KONOWIECKI JOSEPH S Director Sep 13 '24 Sale 12.00 25,000 300,012 1,158,221 Sep 13 06:21 PM KONOWIECKI JOSEPH S Director Sep 12 '24 Sale 11.00 25,000 275,092 1,183,221 Sep 13 06:21 PM Freeman Robert Thomas Chief Financial Officer Sep 12 '24 Sale 11.00 120,500 1,326,054 278,929 Sep 13 06:19 PM Freeman Robert Thomas Chief Financial Officer Sep 13 '24 Sale 12.00 14,500 174,013 264,429 Sep 13 06:19 PM Freeman Robert Thomas Chief Financial Officer Sep 11 '24 Sale 10.01 8,561 85,688 399,429 Sep 13 06:19 PM MARGOLIS FAMILY TRUST U/A DTD1 Officer Sep 13 '24 Proposed Sale 11.58 4,200 48,636 Sep 13 04:23 PM KONOWIECKI JOSEPH S Director Sep 13 '24 Proposed Sale 11.95 25,000 298,748 Sep 13 01:20 PM HAKAN KARDES Officer Sep 12 '24 Proposed Sale 10.75 25,000 268,750 Sep 12 04:28 PM FCO HOLDINGS LLC Officer Sep 12 '24 Proposed Sale 10.75 137,000 1,472,750 Sep 12 04:28 PM KONOWIECKI JOSEPH S Director Sep 12 '24 Proposed Sale 10.95 25,000 273,834 Sep 12 03:54 PM Christopher Joyce Officer Sep 11 '24 Proposed Sale 9.45 24,467 231,213 Sep 11 09:46 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 05 '24 Sale 10.00 4,541 45,422 399,738 Sep 06 05:29 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Sep 04 '24 Sale 10.00 1,300 13,000 404,279 Sep 06 05:29 PM Freeman Robert Thomas Chief Financial Officer Sep 05 '24 Sale 10.00 4,789 47,913 407,990 Sep 06 05:28 PM Freeman Robert Thomas Chief Financial Officer Sep 04 '24 Sale 10.00 1,650 16,500 412,779 Sep 06 05:28 PM CHRISTOPHER J. JOYCE Officer Sep 04 '24 Proposed Sale 9.81 16,667 163,503 Sep 04 04:18 PM Maroney Dawn Christine President, Markets Aug 22 '24 Sale 9.02 7,074 63,780 1,789,023 Aug 23 05:27 PM Maroney Dawn Christine President, Markets Aug 23 '24 Sale 9.06 2,926 26,510 1,786,097 Aug 23 05:27 PM Maroney Dawn Christine President, Markets Aug 15 '24 Sale 8.70 20,000 174,020 1,796,097 Aug 16 04:51 PM MARGOLIS JEFFREY H Director Aug 14 '24 Sale 8.83 1,200 10,596 413,533 Aug 16 04:47 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Aug 02 '24 Sale 9.00 1,333 11,998 405,579 Aug 06 06:13 PM KONOWIECKI JOSEPH S Director Jul 17 '24 Sale 10.00 25,000 250,001 1,208,221 Jul 19 08:27 PM Maroney Dawn Christine President, Markets Jul 18 '24 Sale 10.00 40,137 401,378 1,852,797 Jul 19 08:24 PM Maroney Dawn Christine President, Markets Jul 19 '24 Sale 10.01 36,700 367,209 1,816,097 Jul 19 08:24 PM Maroney Dawn Christine President, Markets Jul 17 '24 Sale 10.00 23,163 231,642 1,892,934 Jul 19 08:24 PM Freeman Robert Thomas Chief Financial Officer Jul 18 '24 Sale 10.00 44,042 440,433 453,287 Jul 19 08:22 PM Freeman Robert Thomas Chief Financial Officer Jul 19 '24 Sale 10.01 38,858 388,790 414,429 Jul 19 08:22 PM Freeman Robert Thomas Chief Financial Officer Jul 17 '24 Sale 10.00 22,100 221,013 497,329 Jul 19 08:22 PM Kardes Hakan Chief Experience Officer Jul 16 '24 Sale 9.98 25,000 249,500 405,444 Jul 18 04:41 PM KONOWIECKI JOSEPH S Chairman of the Board Jul 15 '24 Sale 9.06 22,400 203,036 1,233,221 Jul 16 08:29 PM KONOWIECKI JOSEPH S Chairman of the Board Jul 12 '24 Sale 9.00 2,600 23,403 1,255,621 Jul 16 08:29 PM MARGOLIS JEFFREY H Director Jul 15 '24 Sale 8.94 1,200 10,728 414,733 Jul 16 04:33 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 15 '24 Sale 9.05 15,034 136,032 406,912 Jul 16 04:30 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 12 '24 Sale 9.00 300 2,700 421,946 Jul 16 04:30 PM Maroney Dawn Christine President, Markets Jul 15 '24 Sale 9.04 39,700 358,690 1,916,097 Jul 16 04:29 PM Maroney Dawn Christine President, Markets Jul 12 '24 Sale 9.00 300 2,700 1,955,797 Jul 16 04:29 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jul 01 '24 Sale 8.00 666 5,328 422,246 Jul 03 05:37 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Jun 14 '24 Sale 8.01 16,000 128,198 422,912 Jun 17 08:29 PM MARGOLIS JEFFREY H Director Jun 14 '24 Sale 8.06 1,200 9,672 415,933 Jun 17 08:28 PM Maroney Dawn Christine President, Markets Jun 12 '24 Sale 8.21 20,000 164,200 1,956,097 Jun 14 05:49 PM Scavo Robert L. Chief Information Officer Mar 28 '24 Sale 4.84 1,821 8,814 436,822 Mar 29 08:00 PM Maroney Dawn Christine President, Markets Mar 28 '24 Sale 4.84 10,151 49,131 1,976,097 Mar 29 08:00 PM Freeman Robert Thomas Chief Financial Officer Mar 28 '24 Sale 4.84 4,299 20,807 865,407 Mar 29 08:00 PM Kardes Hakan Chief Experience Officer Mar 28 '24 Sale 4.84 4,363 21,117 430,444 Mar 29 08:00 PM Maroney Dawn Christine President, Markets Mar 19 '24 Sale 5.05 15,861 80,111 1,999,500 Mar 21 05:00 PM Maroney Dawn Christine President, Markets Mar 20 '24 Sale 4.83 13,252 64,007 1,986,248 Mar 21 05:00 PM Scavo Robert L. Chief Information Officer Mar 19 '24 Sale 5.05 3,078 15,546 438,643 Mar 21 05:00 PM JOYCE CHRISTOPHER J Chief Legal and Admin. Officer Mar 19 '24 Sale 5.05 25,060 126,573 438,912 Mar 21 05:00 PM Kim Hyong Chief Medical Officer Mar 19 '24 Sale 5.05 5,576 28,163 555,530 Mar 21 05:00 PM Kardes Hakan Chief Experience Officer Mar 19 '24 Sale 5.05 18,964 95,783 434,807 Mar 21 05:00 PM Freeman Robert Thomas Chief Financial Officer Mar 19 '24 Sale 5.05 28,522 144,059 869,706 Mar 21 05:00 PM KAO JOHN E Chief Executive Officer Mar 14 '24 Buy 4.82 103,000 496,779 2,745,253 Mar 18 05:27 PM Scavo Robert L. Chief Information Officer Mar 15 '24 Sale 4.89 4,852 23,732 441,721 Mar 15 08:00 PM Maroney Dawn Christine President, Markets Mar 15 '24 Sale 4.89 21,537 105,340 2,015,361 Mar 15 08:00 PM Freeman Robert Thomas Chief Financial Officer Mar 15 '24 Sale 4.89 11,858 57,999 898,228 Mar 15 08:00 PM Kardes Hakan Chief Experience Officer Mar 15 '24 Sale 4.89 4,326 21,159 453,771 Mar 15 08:00 PM Maroney Dawn Christine President, Markets Mar 08 '24 Sale 5.44 23,000 125,076 1,830,008 Mar 12 06:00 PM MARGOLIS JEFFREY H Director Dec 14 '23 Sale 8.46 1,200 10,152 417,133 Dec 15 05:00 PM MARGOLIS JEFFREY H Director Dec 06 '23 Sale 8.00 1,200 9,600 418,333 Dec 07 08:00 AM KONOWIECKI JOSEPH S Chairman of the Board Nov 10 '23 Sale 5.90 4,898 28,898 1,188,221 Nov 15 08:24 PM
Index - P/E - EPS (ttm) -123.67 Insider Own 65.05% Shs Outstand 8.05M Perf Week -7.53%
Market Cap 45.63M Forward P/E - EPS next Y -11.79 Insider Trans -0.01% Shs Float 2.89M Perf Month 6.60%
Income -988.60M PEG - EPS next Q -2.92 Inst Own 5.93% Short Float 1.17% Perf Quarter -8.30%
Sales 1.03B P/S 0.04 EPS this Y 85.38% Inst Trans 0.19% Short Ratio 4.18 Perf Half Y -14.68%
Book/sh -157.84 P/B - EPS next Y -14.03% ROA -16.80% Short Interest 0.03M Perf Year -23.66%
Cash/sh - P/C - EPS next 5Y 44.80% ROE -903.84% 52W Range 4.69 - 16.59 Perf YTD -27.77%
Dividend Est. - P/FCF - EPS past 5Y -79.91% ROI - 52W High -66.78% Beta 0.80
Dividend TTM - Quick Ratio - Sales past 5Y 94.90% Gross Margin - 52W Low 17.51% ATR (14) 0.24
Dividend Ex-Date - Current Ratio 0.75 EPS Y/Y TTM 26.04% Oper. Margin -14.61% RSI (14) 51.43 Volatility 3.21% 3.94%
Employees 1252 Debt/Eq - Sales Y/Y TTM -68.09% Profit Margin -95.67% Recom 3.00 Target Price 32.00
Option/Short No / Yes LT Debt/Eq - EPS Q/Q 44.90% Payout - Rel Volume 0.01 Prev Close 5.54
Sales Surprise -10.49% EPS Surprise -113.29% Sales Q/Q -24.16% Earnings Nov 07 BMO Avg Volume 8.10K Price 5.51
SMA20 0.45% SMA50 4.72% SMA200 -15.31% Trades
Volume 18 Change -0.44%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-11-22 Downgrade JP Morgan
Neutral → Underweight
Mar-29-22 Downgrade JP Morgan
Overweight → Neutral
Mar-04-22 Downgrade RBC Capital Mkts
Outperform → Sector Perform
$9 → $3
Mar-02-22 Downgrade BofA Securities
Buy → Underperform
Jan-10-22 Resumed Citigroup
Neutral
$5 → $3.50
Dec-16-21 Downgrade Morgan Stanley
Equal-Weight → Underweight
$5 → $4
Dec-14-21 Initiated Goldman
Neutral
$5
Dec-10-21 Upgrade JP Morgan
Neutral → Overweight
$6
Nov-12-21 Downgrade Morgan Stanley
Overweight → Equal-Weight
$13 → $5
Nov-02-21 Downgrade Cowen
Outperform → Market Perform
$14 → $9
Nov-01-21 Downgrade Citigroup
Buy → Neutral
Sep-10-21 Initiated Cowen
Outperform
$14
Aug-04-21 Upgrade Morgan Stanley
Equal-Weight → Overweight
$12
Aug-04-21 Upgrade Citigroup
Neutral → Buy
$16 → $12
Jul-19-21 Initiated Wolfe Research
Peer Perform
$15
Jul-19-21 Initiated RBC Capital Mkts
Outperform
$22
Jul-19-21 Initiated Piper Sandler
Overweight
$24
Jul-19-21 Initiated Morgan Stanley
Equal-Weight
$18
Jul-19-21 Initiated JP Morgan
Neutral
$19
Jul-19-21 Initiated Goldman
Buy
$36
Show Previous Ratings
Oct-17-24 08:00AM
Sep-19-24 12:00PM
Aug-07-24 06:45AM
Jul-18-24 08:00AM
Jun-24-24 06:45AM
04:30PM
Loading…
Jun-18-24 04:30PM
Jun-06-24 07:47AM
May-11-24 08:41AM
May-08-24 06:45AM
Apr-18-24 08:00AM
Apr-09-24 05:29PM
Mar-06-24 08:01AM
06:45AM
Feb-20-24 08:00AM
Jan-18-24 05:38AM
04:05PM
Loading…
Jan-17-24 04:05PM
Jan-02-24 04:30PM
(Business Wire) +8.13%
+10.91%
Dec-29-23 06:45AM
Nov-09-23 01:23PM
Nov-07-23 09:33AM
(Associated Press Finance)
07:26AM
06:45AM
Oct-13-23 08:00AM
Sep-19-23 06:45AM
Aug-09-23 08:53PM
(Thomson Reuters StreetEvents) -12.34%
-10.84%
08:05AM
06:54AM
(Associated Press Finance)
06:45AM
Aug-07-23 06:45AM
Aug-02-23 08:15AM
08:00AM
Loading…
Jul-17-23 08:00AM
Jul-13-23 06:20AM
Jul-12-23 03:29PM
Jul-03-23 12:24PM
08:41AM
Jun-30-23 06:45AM
Jun-09-23 07:59AM
May-09-23 08:05AM
06:57AM
06:45AM
May-03-23 05:00PM
Apr-28-23 08:00AM
Apr-25-23 04:05PM
Mar-29-23 07:20AM
Mar-02-23 09:19PM
05:38AM
02:30AM
(Thomson Reuters StreetEvents)
Mar-01-23 08:05AM
06:45AM
Feb-22-23 08:05PM
Feb-14-23 07:08AM
Feb-10-23 01:50PM
08:00AM
Feb-01-23 03:15PM
(American City Business Journals) +7.35%
Jan-18-23 05:51AM
(Simply Wall St.) -16.34%
Jan-10-23 07:00AM
Jan-04-23 12:00PM
Dec-21-22 08:46AM
Dec-12-22 04:30PM
(Business Wire) +5.93%
-16.12%
Nov-10-22 04:30PM
(Business Wire) +14.26%
-8.54%
Nov-09-22 03:37PM
02:42PM
(American City Business Journals)
08:05AM
Nov-07-22 08:05AM
Oct-19-22 07:30AM
Oct-18-22 07:30AM
Oct-11-22 03:16PM
(American City Business Journals) +28.57%
07:00AM
Sep-13-22 02:22PM
Aug-10-22 04:00PM
07:55AM
06:45AM
Aug-08-22 05:45PM
Aug-05-22 03:06PM
(American City Business Journals)
Aug-04-22 06:15PM
Jul-26-22 08:00AM
Jul-25-22 05:45PM
Jul-22-22 11:25AM
Jun-22-22 11:18AM
May-17-22 04:05PM
May-08-22 08:21AM
May-04-22 04:01PM
06:45AM
Apr-19-22 08:30AM
Apr-14-22 05:26PM
(American City Business Journals)
-5.91%
05:00PM
04:13PM
(American City Business Journals)
Apr-07-22 08:00AM
Apr-06-22 01:58PM
Mar-15-22 04:35PM
Mar-02-22 06:45AM
Mar-01-22 08:10AM
Feb-14-22 07:32PM
(PR Newswire) -22.51%
+20.27%
08:00AM
Feb-02-22 01:38PM
09:38AM
Jan-20-22 09:01AM
Jan-18-22 10:11AM
Jan-10-22 08:00AM
Jan-05-22 08:00AM
NeueHealth, Inc. engages in the provision of healthcare products and services for consumers and care providers in local markets. It offers individual and family, and Medicare Advantage health plans. It operates through the Bright HealthCare and NeueHealth segments. The Bright HealthCare segment offers commercial and Medicare health plan products. The NeueHealth segment provides care delivery and value-based enablement services. The company was founded by Robert J. Sheehy, Tomas Valdivia, and Kyle Rolfing in 2015 and is headquartered in Doral, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Matushak Jay Chief Financial Officer Oct 07 '24 Sale 5.18 87 451 9,480 Oct 08 06:08 PM IMMELT JEFFREY R Director May 12 '24 Option Exercise 0.00 4,755 0 13,419 May 14 09:59 PM Kadre Manuel Director May 12 '24 Option Exercise 0.00 4,755 0 19,320 May 14 09:50 PM Kraus Stephen Director May 12 '24 Option Exercise 0.00 4,755 0 5,944 May 14 09:27 PM Manders Matthew G Director May 12 '24 Option Exercise 0.00 4,755 0 6,241 May 14 09:09 PM Sheehy Robert J Director May 12 '24 Option Exercise 0.00 4,755 0 4,755 May 14 08:41 PM Makhzoumi Mohamad Director May 12 '24 Option Exercise 0.00 4,755 0 5,943 May 14 08:25 PM Gooden Linda R Director May 12 '24 Option Exercise 0.00 4,755 0 99,864 May 14 07:40 PM Slavitt Andrew M Director May 12 '24 Option Exercise 0.00 4,755 0 8,029 May 14 07:38 PM ADKINS KEDRICK D JR Director May 12 '24 Option Exercise 0.00 4,755 0 99,864 May 14 07:36 PM Scherman Jeffrey J Chief Accounting Officer May 10 '24 Sale 6.05 113 684 3,670 May 13 06:21 PM Matushak Jay Chief Financial Officer May 10 '24 Sale 6.05 317 1,918 9,304 May 13 05:58 PM Scherman Jeffrey J Chief Accounting Officer Mar 18 '24 Sale 7.27 568 4,129 3,440 Mar 20 08:12 PM Orozco Tomas EVP, Consumer Care Mar 18 '24 Sale 7.27 822 5,976 5,092 Mar 20 08:09 PM Craig Jeffery Michael GC & Corporate Secretary Mar 18 '24 Sale 7.27 260 1,890 3,426 Mar 20 08:06 PM Matushak Jay Chief Financial Officer Mar 18 '24 Sale 7.27 1,083 7,873 8,643 Mar 20 08:04 PM Mikan George Lawrence III CEO & President Mar 18 '24 Sale 7.27 4,990 36,277 64,832 Mar 20 08:01 PM Scherman Jeffrey J Chief Accounting Officer Mar 15 '24 Sale 7.10 98 696 4,008 Mar 18 08:22 PM Scherman Jeffrey J Chief Accounting Officer Mar 14 '24 Sale 7.06 68 480 4,106 Mar 18 08:22 PM Orozco Tomas EVP, Consumer Care Mar 15 '24 Sale 7.10 79 561 5,914 Mar 18 08:21 PM Orozco Tomas EVP, Consumer Care Mar 14 '24 Sale 7.06 54 381 5,993 Mar 18 08:21 PM Craig Jeffery Michael GC & Corporate Secretary Mar 15 '24 Sale 7.10 151 1,072 3,686 Mar 18 08:20 PM Craig Jeffery Michael GC & Corporate Secretary Mar 14 '24 Sale 7.06 105 741 3,837 Mar 18 08:20 PM Matushak Jay Chief Financial Officer Mar 15 '24 Sale 7.10 248 1,761 9,726 Mar 18 08:17 PM Matushak Jay Chief Financial Officer Mar 14 '24 Sale 7.06 173 1,221 9,974 Mar 18 08:17 PM Mikan George Lawrence III CEO & President Mar 15 '24 Sale 7.10 3,442 24,438 69,822 Mar 18 08:14 PM Mikan George Lawrence III CEO & President Mar 14 '24 Sale 7.06 2,398 16,930 73,264 Mar 18 08:14 PM Scherman Jeffrey J Chief Accounting Officer Mar 13 '24 Sale 7.30 99 723 4,174 Mar 13 09:30 PM Scherman Jeffrey J Chief Accounting Officer Mar 11 '24 Sale 8.11 76 616 4,318 Mar 13 09:30 PM Scherman Jeffrey J Chief Accounting Officer Mar 12 '24 Sale 7.76 45 349 4,273 Mar 13 09:30 PM Craig Jeffery Michael GC & Corporate Secretary Mar 13 '24 Sale 7.30 152 1,110 3,942 Mar 13 09:26 PM Craig Jeffery Michael GC & Corporate Secretary Mar 11 '24 Sale 8.11 117 949 4,164 Mar 13 09:26 PM Craig Jeffery Michael GC & Corporate Secretary Mar 12 '24 Sale 7.76 70 543 4,094 Mar 13 09:26 PM Orozco Tomas EVP, Consumer Care Mar 13 '24 Sale 7.30 78 569 6,047 Mar 13 09:24 PM Orozco Tomas EVP, Consumer Care Mar 11 '24 Sale 8.11 60 487 6,161 Mar 13 09:24 PM Orozco Tomas EVP, Consumer Care Mar 12 '24 Sale 7.76 36 279 6,125 Mar 13 09:24 PM Matushak Jay Chief Financial Officer Mar 13 '24 Sale 7.30 251 1,832 10,147 Mar 13 09:23 PM Matushak Jay Chief Financial Officer Mar 11 '24 Sale 8.11 193 1,565 10,514 Mar 13 09:23 PM Matushak Jay Chief Financial Officer Mar 12 '24 Sale 7.76 116 900 10,398 Mar 13 09:23 PM Mikan George Lawrence III CEO & President Mar 13 '24 Sale 7.30 3,463 25,280 75,662 Mar 13 09:21 PM Mikan George Lawrence III CEO & President Mar 11 '24 Sale 8.11 2,664 21,605 80,723 Mar 13 09:21 PM Mikan George Lawrence III CEO & President Mar 12 '24 Sale 7.76 1,598 12,400 79,125 Mar 13 09:21 PM Scherman Jeffrey J Chief Accounting Officer Mar 07 '24 Sale 9.88 224 2,213 4,539 Mar 11 09:30 PM Scherman Jeffrey J Chief Accounting Officer Mar 08 '24 Sale 8.42 145 1,221 4,394 Mar 11 09:30 PM Orozco Tomas EVP, Consumer Care Mar 07 '24 Sale 9.88 179 1,769 6,336 Mar 11 09:28 PM Orozco Tomas EVP, Consumer Care Mar 08 '24 Sale 8.42 115 968 6,221 Mar 11 09:28 PM Craig Jeffery Michael GC & Corporate Secretary Mar 07 '24 Sale 9.88 347 3,428 4,505 Mar 11 09:27 PM Craig Jeffery Michael GC & Corporate Secretary Mar 08 '24 Sale 8.42 224 1,886 4,281 Mar 11 09:27 PM Matushak Jay Chief Financial Officer Mar 07 '24 Sale 9.88 570 5,632 11,076 Mar 11 09:24 PM Matushak Jay Chief Financial Officer Mar 08 '24 Sale 8.42 369 3,107 10,707 Mar 11 09:24 PM Mikan George Lawrence III CEO & President Mar 07 '24 Sale 9.88 7,886 77,914 88,483 Mar 11 09:22 PM Mikan George Lawrence III CEO & President Mar 08 '24 Sale 8.42 5,096 42,908 83,387 Mar 11 09:22 PM Mikan George Lawrence III CEO & President Dec 15 '23 Sale 6.14 25,202 154,740 29,927 Dec 18 09:14 PM
Index RUT P/E - EPS (ttm) -0.13 Insider Own 28.39% Shs Outstand 193.87M Perf Week -9.89%
Market Cap 3.88B Forward P/E 27.03 EPS next Y 0.59 Insider Trans -0.83% Shs Float 173.22M Perf Month -26.12%
Income 18.15M PEG - EPS next Q -0.17 Inst Own 59.77% Short Float 6.94% Perf Quarter 4.70%
Sales 7.23B P/S 0.54 EPS this Y 105.05% Inst Trans 13.10% Short Ratio 4.10 Perf Half Y -8.81%
Book/sh 4.71 P/B 3.41 EPS next Y 863.96% ROA 0.40% Short Interest 12.02M Perf Year 222.09%
Cash/sh - P/C - EPS next 5Y 71.00% ROE 1.74% 52W Range 4.72 - 23.79 Perf YTD 75.30%
Dividend Est. - P/FCF 15.34 EPS past 5Y -2.85% ROI 1.26% 52W High -32.58% Beta 1.61
Dividend TTM - Quick Ratio - Sales past 5Y 113.90% Gross Margin - 52W Low 239.83% ATR (14) 0.99
Dividend Ex-Date - Current Ratio 0.96 EPS Y/Y TTM 102.17% Oper. Margin 0.69% RSI (14) 33.20 Volatility 5.36% 5.82%
Employees 2400 Debt/Eq 0.26 Sales Y/Y TTM 45.69% Profit Margin 0.25% Recom 1.86 Target Price 26.86
Option/Short Yes / Yes LT Debt/Eq 0.26 EPS Q/Q 388.28% Payout - Rel Volume 0.50 Prev Close 16.03
Sales Surprise 1.46% EPS Surprise 23.69% Sales Q/Q 45.86% Earnings Nov 07 BMO Avg Volume 2.93M Price 16.04
SMA20 -12.61% SMA50 -15.01% SMA200 -5.79% Trades
Volume 236,809 Change 0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-07-24 Initiated UBS
Neutral
$23
Jun-26-24 Initiated Piper Sandler
Overweight
$25
May-30-24 Initiated Robert W. Baird
Outperform
$28
May-30-24 Downgrade BofA Securities
Buy → Neutral
$25 → $21
Mar-22-24 Initiated Raymond James
Outperform
$20
Nov-02-23 Upgrade BofA Securities
Neutral → Buy
$8 → $9
Jun-06-23 Upgrade BofA Securities
Underperform → Neutral
$5.40 → $8.75
Nov-16-22 Upgrade Wells Fargo
Equal Weight → Overweight
$4
Nov-14-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$5
Jun-15-22 Downgrade BofA Securities
Neutral → Underperform
$6 → $4.50
May-26-22 Downgrade BofA Securities
Buy → Neutral
$12 → $6
Feb-14-22 Downgrade Goldman
Neutral → Sell
$6.50 → $9
Jan-06-22 Downgrade Wells Fargo
Overweight → Equal Weight
$25 → $9
Dec-14-21 Initiated Goldman
Sell
$6.50
Sep-10-21 Initiated Cowen
Market Perform
$15
Mar-30-21 Initiated Wells Fargo
Overweight
$37
Mar-29-21 Initiated Morgan Stanley
Overweight
$44
Mar-29-21 Initiated Goldman
Buy
$44
Mar-29-21 Initiated Credit Suisse
Outperform
$34
Mar-29-21 Initiated Cowen
Market Perform
$29
Show Previous Ratings
Oct-22-24 06:15PM
Oct-21-24 06:45AM
Oct-15-24 06:15PM
Oct-11-24 05:30AM
(The Wall Street Journal)
Oct-08-24 06:15PM
08:50AM
Loading…
08:50AM
08:00AM
Oct-07-24 02:12PM
Oct-04-24 09:30AM
Sep-30-24 06:15PM
Sep-29-24 06:33AM
Sep-23-24 03:18PM
(Investor's Business Daily)
Sep-20-24 06:00PM
Sep-12-24 06:00PM
02:30PM
(Investor's Business Daily)
01:26PM
Loading…
01:26PM
(Investor's Business Daily)
09:31AM
09:30AM
Aug-22-24 08:00AM
Aug-14-24 11:58AM
11:33AM
Aug-07-24 07:15AM
06:30AM
06:00AM
Aug-05-24 11:56AM
Jul-31-24 06:00PM
10:01AM
03:38AM
Jul-25-24 09:40AM
Jul-24-24 06:38AM
10:16AM
Loading…
Jul-22-24 10:16AM
Jul-16-24 06:00PM
Jul-11-24 06:15PM
Jul-09-24 08:00AM
Jul-08-24 12:26PM
Jun-26-24 06:15AM
Jun-19-24 06:30AM
Jun-07-24 07:01PM
Jun-05-24 02:38AM
02:38AM
02:38AM
02:37AM
Jun-04-24 09:30AM
Jun-03-24 06:30AM
May-27-24 08:50AM
May-13-24 09:15AM
May-09-24 05:01PM
08:50AM
May-08-24 11:36AM
08:00AM
May-07-24 04:07PM
(Investor's Business Daily)
01:52PM
12:39PM
10:54AM
09:18AM
08:54AM
08:31AM
07:34AM
07:10AM
07:04AM
(Investor's Business Daily)
06:00AM
May-03-24 08:00AM
(Investor's Business Daily)
08:00AM
(Investor's Business Daily)
Apr-22-24 02:11PM
(Investor's Business Daily)
Apr-20-24 09:16AM
Apr-10-24 08:00AM
Apr-02-24 08:00AM
Mar-01-24 03:40AM
Feb-28-24 08:50AM
Feb-21-24 09:21AM
Feb-12-24 08:50AM
Feb-08-24 04:44PM
(Yahoo Finance Video) +24.38%
+6.00%
11:50AM
09:40AM
07:03AM
(Thomson Reuters StreetEvents)
Feb-07-24 04:47PM
04:05PM
Feb-01-24 04:03AM
Jan-26-24 08:00AM
Jan-18-24 08:00AM
Jan-11-24 07:03AM
Jan-03-24 08:50AM
Dec-20-23 08:00AM
Dec-11-23 08:51AM
Dec-08-23 01:05AM
Dec-05-23 09:41PM
Dec-04-23 08:50AM
Nov-20-23 04:05PM
06:00AM
Nov-16-23 10:59AM
Nov-15-23 12:00PM
Nov-08-23 10:50AM
08:00AM
12:02AM
(Thomson Reuters StreetEvents)
Nov-07-23 06:50PM
06:38AM
06:00AM
Nov-06-23 09:55AM
Nov-03-23 05:23AM
Oct-31-23 12:00PM
Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Quane Alessandrea C. EVP, Chief Insurance Officer Sep 06 '24 Sale 17.06 16,793 286,489 392,607 Sep 09 04:52 PM Blackley Richard Scott Chief Financial Officer Sep 06 '24 Sale 17.06 29,957 511,066 853,875 Sep 09 04:51 PM Blackley Richard Scott Chief Financial Officer Sep 03 '24 Sale 17.99 68,978 1,240,914 884,213 Sep 04 08:58 PM Blackley Richard Scott Chief Financial Officer Sep 04 '24 Sale 17.64 62,881 1,108,922 821,332 Sep 04 08:58 PM Schlosser Mario President of Technology & CTO Sep 03 '24 Sale 17.99 3,198 57,532 76,982 Sep 04 08:42 PM Schlosser Mario President of Technology & CTO Sep 04 '24 Sale 17.64 2,916 51,425 74,066 Sep 04 08:42 PM Bopitiya Ranmali EVP & Chief Legal Officer Sep 03 '24 Sale 17.99 36,175 650,788 251,885 Sep 04 08:42 PM Bopitiya Ranmali EVP & Chief Legal Officer Sep 04 '24 Sale 17.64 32,978 581,576 218,907 Sep 04 08:42 PM Wolin Steven Chief Operating Officer Sep 03 '24 Sale 17.99 10,242 184,254 93,051 Sep 04 08:41 PM Wolin Steven Chief Operating Officer Sep 04 '24 Sale 17.64 9,337 164,660 83,714 Sep 04 08:41 PM Baltrus Victoria Chief Accounting Officer Sep 03 '24 Sale 17.99 4,226 76,026 140,648 Sep 04 08:36 PM Baltrus Victoria Chief Accounting Officer Sep 04 '24 Sale 17.64 3,852 67,931 136,796 Sep 04 08:36 PM Quane Alessandrea C. EVP, Chief Insurance Officer Sep 03 '24 Sale 17.99 77,181 1,388,486 448,506 Sep 04 08:36 PM Quane Alessandrea C. EVP, Chief Insurance Officer Sep 04 '24 Sale 17.64 70,356 1,240,746 378,150 Sep 04 08:36 PM Quane Alessandrea C. EVP, Chief Insurance Officer Sep 03 '24 Proposed Sale 18.30 162,291 2,969,925 Sep 03 05:00 PM Wolin Steven Chief Operating Officer Sep 03 '24 Proposed Sale 18.30 21,537 394,127 Sep 03 05:00 PM Blackley Richard Scott Chief Financial Officer Sep 03 '24 Proposed Sale 18.30 145,045 2,654,324 Sep 03 05:00 PM Schlosser Mario Director, President of Technol Sep 03 '24 Proposed Sale 18.30 6,725 123,068 Sep 03 05:00 PM Ranmali Bopitiya EVP & Chief Legal Officer Sep 03 '24 Proposed Sale 18.30 76,068 1,392,044 Sep 03 05:00 PM Quane Alessandrea C. EVP, Chief Insurance Officer Jun 06 '24 Sale 19.58 16,793 328,807 251,136 Jun 07 04:23 PM Blackley Richard Scott Chief Financial Officer Jun 06 '24 Sale 19.58 29,978 586,969 675,442 Jun 07 04:20 PM Quane Alessandrea C. EVP, Chief Insurance Officer Jun 03 '24 Sale 19.46 25,550 497,203 237,347 Jun 04 06:07 PM Quane Alessandrea C. EVP, Chief Insurance Officer Jun 04 '24 Sale 19.09 668 12,752 236,679 Jun 04 06:07 PM Wolin Steven Chief Operating Officer Jun 03 '24 Sale 19.46 18,607 362,092 65,316 Jun 04 06:06 PM Wolin Steven Chief Operating Officer Jun 04 '24 Sale 19.09 486 9,278 64,830 Jun 04 06:06 PM Schlosser Mario President of Technology & CTO Jun 03 '24 Sale 19.46 5,808 113,024 65,920 Jun 04 06:05 PM Schlosser Mario President of Technology & CTO Jun 04 '24 Sale 19.09 152 2,902 65,768 Jun 04 06:05 PM Bopitiya Ranmali EVP & Chief Legal Officer Jun 03 '24 Sale 19.46 17,168 334,089 137,835 Jun 04 06:05 PM Bopitiya Ranmali EVP & Chief Legal Officer Jun 04 '24 Sale 19.09 447 8,533 137,388 Jun 04 06:05 PM Blackley Richard Scott Chief Financial Officer Jun 03 '24 Sale 19.46 24,016 467,351 643,546 Jun 04 06:05 PM Blackley Richard Scott Chief Financial Officer Jun 04 '24 Sale 19.09 626 11,950 642,920 Jun 04 06:05 PM Baltrus Victoria Chief Accounting Officer Jun 03 '24 Sale 19.46 7,674 149,336 127,754 Jun 04 06:04 PM Baltrus Victoria Chief Accounting Officer Jun 04 '24 Sale 19.09 199 3,799 127,555 Jun 04 06:04 PM Blackley Richard Scott Chief Financial Officer Mar 06 '24 Sale 14.12 27,043 381,847 614,316 Mar 07 04:18 PM Quane Alessandrea C. EVP, Chief Insurance Officer Mar 06 '24 Sale 14.12 13,233 186,850 212,850 Mar 07 04:18 PM Bopitiya Ranmali EVP & Chief Legal Officer Mar 04 '24 Sale 15.88 11,426 181,445 113,264 Mar 05 04:23 PM Blackley Richard Scott Chief Financial Officer Mar 04 '24 Sale 15.88 14,346 227,814 578,859 Mar 05 04:23 PM Quane Alessandrea C. EVP, Chief Insurance Officer Mar 04 '24 Sale 15.88 15,928 252,937 194,833 Mar 05 04:23 PM Baltrus Victoria Chief Accounting Officer Mar 04 '24 Sale 15.88 33,707 535,267 118,111 Mar 05 04:22 PM Quane Alessandrea C. EVP, Chief Insurance Officer Feb 16 '24 Sale 18.02 55,000 991,100 169,366 Feb 21 04:21 PM Bopitiya Ranmali EVP & Chief Legal Officer Feb 16 '24 Sale 18.03 42,865 772,856 87,818 Feb 21 04:21 PM Quane Alessandrea C. EVP, Chief Insurance Officer Dec 06 '23 Sale 8.16 16,793 137,031 301,223 Dec 07 04:18 PM Blackley Richard Scott Chief Financial Officer Dec 06 '23 Sale 8.16 30,029 245,037 548,613 Dec 07 04:17 PM Blackley Richard Scott Chief Financial Officer Dec 04 '23 Sale 8.34 21,171 176,566 516,142 Dec 05 04:22 PM Quane Alessandrea C. EVP, Chief Insurance Officer Dec 04 '23 Sale 8.34 22,246 185,532 286,766 Dec 05 04:22 PM Baltrus Victoria Chief Accounting Officer Dec 04 '23 Sale 8.34 5,068 42,267 59,743 Dec 05 04:21 PM Bopitiya Ranmali EVP & Chief Legal Officer Dec 04 '23 Sale 8.34 12,625 105,292 130,683 Dec 05 04:20 PM Schlosser Mario President of Technology & CTO Nov 16 '23 Sale 7.12 390,405 2,779,020 57,317 Nov 20 04:28 PM
Index RUT P/E - EPS (ttm) -0.45 Insider Own 29.25% Shs Outstand 41.86M Perf Week -3.17%
Market Cap 2.18B Forward P/E 914.15 EPS next Y 0.06 Insider Trans 0.05% Shs Float 29.83M Perf Month 22.33%
Income -18.91M PEG - EPS next Q -0.06 Inst Own 89.74% Short Float 34.85% Perf Quarter 50.68%
Sales 1.20B P/S 1.82 EPS this Y 71.71% Inst Trans -4.11% Short Ratio 15.84 Perf Half Y 116.67%
Book/sh 7.25 P/B 7.14 EPS next Y 118.55% ROA -2.48% Short Interest 10.40M Perf Year 127.61%
Cash/sh - P/C - EPS next 5Y 39.30% ROE -6.36% 52W Range 19.14 - 55.74 Perf YTD 69.80%
Dividend Est. - P/FCF 91.42 EPS past 5Y -106.11% ROI -4.36% 52W High -7.06% Beta 1.74
Dividend TTM - Quick Ratio - Sales past 5Y 29.66% Gross Margin - 52W Low 170.65% ATR (14) 2.19
Dividend Ex-Date - Current Ratio 1.63 EPS Y/Y TTM 69.42% Oper. Margin -1.20% RSI (14) 62.90 Volatility 4.25% 4.59%
Employees 1142 Debt/Eq 0.42 Sales Y/Y TTM 19.47% Profit Margin -1.57% Recom 2.33 Target Price 43.86
Option/Short Yes / Yes LT Debt/Eq 0.42 EPS Q/Q 57.97% Payout - Rel Volume 0.34 Prev Close 52.60
Sales Surprise 1.77% EPS Surprise 22.31% Sales Q/Q 16.35% Earnings Oct 30 AMC Avg Volume 656.28K Price 51.81
SMA20 9.52% SMA50 13.63% SMA200 58.39% Trades
Volume 36,617 Change -1.51%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-19-24 Initiated William Blair
Outperform
May-16-24 Upgrade BofA Securities
Neutral → Buy
$35 → $49
May-08-23 Downgrade BofA Securities
Buy → Neutral
$72 → $32
Sep-21-22 Initiated Jefferies
Buy
$77
Aug-04-22 Downgrade Piper Sandler
Overweight → Neutral
$80 → $69
Feb-24-22 Upgrade BofA Securities
Neutral → Buy
$129 → $118
Nov-08-21 Downgrade BofA Securities
Buy → Neutral
$112 → $129
Oct-18-21 Initiated BofA Securities
Buy
$112
Oct-06-21 Initiated Piper Sandler
Overweight
$110
Apr-06-21 Initiated Evercore ISI
Outperform
$100
Aug-10-20 Downgrade Guggenheim
Buy → Neutral
Aug-05-20 Downgrade Northland Capital
Outperform → Market Perform
$42 → $50
Feb-14-20 Downgrade Raymond James
Outperform → Mkt Perform
Jan-09-20 Downgrade Stifel
Buy → Hold
$32 → $38
Aug-16-19 Downgrade Craig Hallum
Buy → Hold
$29
May-23-19 Initiated Guggenheim
Buy
$35
Oct-02-18 Upgrade CL King
Neutral → Buy
Sep-07-18 Initiated Raymond James
Outperform
Aug-03-18 Reiterated Stifel
Buy
$40 → $43
Aug-03-18 Reiterated Lake Street
Buy
$41 → $46
Show Previous Ratings
Today 08:00AM
Oct-15-24 09:00AM
Oct-09-24 05:54PM
Sep-30-24 01:23PM
Sep-27-24 11:42AM
08:00AM
Loading…
Sep-25-24 08:00AM
Sep-16-24 09:00AM
Sep-10-24 06:35AM
(Life Insurance International)
Sep-09-24 12:00PM
Aug-22-24 04:10PM
Aug-14-24 09:00AM
Aug-08-24 07:00PM
06:25PM
05:26PM
(Associated Press Finance)
04:05PM
01:15PM
Loading…
01:15PM
Aug-07-24 09:15AM
Aug-06-24 04:05PM
Aug-05-24 10:19AM
Aug-01-24 04:15PM
10:01AM
Jul-29-24 02:53PM
Jul-18-24 04:15PM
Jul-15-24 11:57AM
Jul-10-24 09:00AM
Jul-08-24 11:44AM
07:11AM
Jun-28-24 02:25AM
Jun-27-24 09:00AM
Jun-26-24 11:08PM
09:00AM
Loading…
Jun-20-24 09:00AM
Jun-19-24 12:38PM
09:00AM
Jun-18-24 09:00AM
Jun-17-24 06:00AM
Jun-12-24 09:30AM
Jun-08-24 12:00PM
Jun-06-24 02:57PM
02:14PM
May-25-24 03:00PM
May-23-24 09:00AM
May-20-24 03:12PM
(Investor's Business Daily)
May-17-24 09:38AM
09:00AM
May-16-24 01:26PM
09:34AM
May-15-24 12:50PM
09:00AM
May-10-24 02:40AM
May-07-24 10:00AM
May-03-24 01:36PM
10:28AM
07:03AM
(Thomson Reuters StreetEvents)
04:03AM
May-02-24 09:56PM
05:56PM
05:42PM
(Associated Press Finance)
04:05PM
04:04PM
Apr-29-24 12:00PM
Apr-25-24 10:02AM
09:00AM
Apr-22-24 09:00AM
Apr-19-24 11:02AM
09:00AM
Apr-18-24 06:30AM
Apr-17-24 12:00PM
Apr-16-24 09:00AM
Apr-02-24 09:00PM
Mar-21-24 04:05PM
Mar-12-24 03:38PM
Mar-04-24 09:00PM
Feb-28-24 04:05PM
Feb-22-24 09:30AM
04:00AM
Feb-19-24 09:30AM
Feb-18-24 03:41PM
Feb-16-24 08:38PM
(Motley Fool) -35.15%
+6.60%
10:23AM
07:41AM
(Thomson Reuters StreetEvents)
Feb-15-24 05:21PM
04:55PM
04:41PM
(Associated Press Finance)
04:05PM
Feb-13-24 05:54PM
Feb-08-24 09:00AM
Jan-30-24 12:00PM
Jan-22-24 07:44PM
Jan-09-24 12:31PM
12:00PM
Dec-27-23 01:24PM
Dec-24-23 01:08PM
Dec-14-23 08:00PM
(GlobeNewswire) +5.94%
-8.25%
Dec-07-23 04:20PM
Dec-04-23 06:30AM
Dec-01-23 02:00AM
Nov-30-23 04:10AM
Nov-28-23 07:00AM
Nov-23-23 03:49PM
Nov-20-23 12:00PM
Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tooth Margaret CEO Aug 28 '24 Option Exercise 6.54 7,500 49,050 107,484 Aug 30 10:29 AM Tooth Margaret CEO Aug 28 '24 Sale 46.48 7,500 348,600 99,984 Aug 30 10:29 AM Tooth Margaret Officer Aug 28 '24 Proposed Sale 47.21 7,500 354,075 Aug 28 04:32 PM Qureshi Fawwad Chief Financial Officer Aug 26 '24 Sale 46.54 624 29,041 0 Aug 27 07:39 PM FAWWAD QURESHI Officer Aug 26 '24 Proposed Sale 46.54 624 29,041 Aug 26 04:15 PM Qureshi Fawwad Chief Financial Officer Aug 16 '24 Sale 43.12 640 27,597 0 Aug 19 05:15 PM Dodson Paulette R. Director Jun 30 '24 Option Exercise 0.00 1,054 0 6,418 Jul 01 02:11 PM RUBIN HOWARD E Director Jun 30 '24 Option Exercise 0.00 568 0 229,973 Jul 01 02:11 PM Broden Max Director Jun 30 '24 Option Exercise 0.00 1,581 0 5,408 Jul 01 02:11 PM MCLAUGHLIN ELIZABETH Director Jun 30 '24 Option Exercise 0.00 1,581 0 7,472 Jul 01 02:11 PM DAVIDSON JACQUELINE L Director Jun 30 '24 Option Exercise 0.00 1,054 0 14,456 Jul 01 02:11 PM WEINRAUCH STEVE EVP, North Am & Vet Strategy May 30 '24 Sale 29.35 1,000 29,350 55,896 Jun 03 07:17 PM HEWITT MELISSA JOY General Manager May 30 '24 Sale 30.04 1,200 36,054 6,105 Jun 03 07:17 PM RAWLINGS DARRYL Chief Executive Officer May 07 '24 Buy 24.14 20,700 499,663 614,842 May 09 06:40 PM DREYER EMILY SVP, Channel Growth May 07 '24 Sale 25.34 3,125 79,201 19,830 May 09 05:56 PM MCLAUGHLIN ELIZABETH Director Mar 31 '24 Option Exercise 0.00 1,582 0 5,891 Apr 03 07:21 PM Dodson Paulette R. Director Mar 31 '24 Option Exercise 0.00 1,055 0 5,364 Apr 03 07:20 PM DAVIDSON JACQUELINE L Director Mar 31 '24 Option Exercise 0.00 1,055 0 13,402 Apr 03 07:20 PM RUBIN HOWARD E Director Mar 31 '24 Option Exercise 0.00 569 0 229,405 Apr 03 07:20 PM LEVITAN DAN Director Mar 31 '24 Option Exercise 0.00 1,582 0 95,116 Apr 03 07:20 PM Satchu Zay Director Mar 31 '24 Option Exercise 0.00 1,582 0 4,788 Apr 03 07:20 PM Broden Max Director Mar 31 '24 Option Exercise 0.00 1,582 0 3,827 Apr 03 07:19 PM Broden Max Director Dec 31 '23 Option Exercise 0.00 1,141 0 2,245 Jan 03 06:28 PM MCLAUGHLIN ELIZABETH Director Dec 31 '23 Option Exercise 0.00 1,560 0 4,309 Jan 03 06:27 PM Satchu Zay Director Dec 31 '23 Option Exercise 0.00 368 0 3,206 Jan 03 06:27 PM DAVIDSON JACQUELINE L Director Dec 31 '23 Option Exercise 0.00 245 0 12,347 Jan 03 06:27 PM Enthoven Richard Director Dec 31 '23 Option Exercise 0.00 485 0 485 Jan 03 06:26 PM LEVITAN DAN Director Dec 31 '23 Option Exercise 0.00 368 0 93,534 Jan 03 06:26 PM RUBIN HOWARD E Director Dec 31 '23 Option Exercise 0.00 245 0 228,836 Jan 03 06:26 PM Dodson Paulette R. Director Dec 31 '23 Option Exercise 0.00 1,560 0 4,309 Jan 03 06:25 PM LOW MURRAY B Director Dec 31 '23 Option Exercise 0.00 245 0 133,513 Jan 03 06:25 PM WEINRAUCH STEVE EVP, North Am & Vet Strategy Dec 04 '23 Option Exercise 8.84 18,322 161,895 50,973 Dec 06 04:56 PM HEWITT MELISSA JOY General Manager Nov 30 '23 Sale 26.27 1,213 31,866 4,999 Dec 04 01:18 PM WEINRAUCH STEVE EVP, North Am & Vet Strategy Nov 30 '23 Sale 26.11 10,170 265,518 32,651 Dec 04 01:15 PM
Index S&P 500 P/E 24.98 EPS (ttm) 12.71 Insider Own 1.89% Shs Outstand 292.50M Perf Week -11.41%
Market Cap 88.80B Forward P/E 9.99 EPS next Y 31.81 Insider Trans -1.02% Shs Float 274.27M Perf Month -10.06%
Income 3.71B PEG 2.24 EPS next Q 7.23 Inst Own 88.88% Short Float 1.12% Perf Quarter -6.89%
Sales 216.01B P/S 0.41 EPS this Y 13.55% Inst Trans -2.14% Short Ratio 2.32 Perf Half Y -9.83%
Book/sh 147.88 P/B 2.15 EPS next Y 11.67% ROA 2.51% Short Interest 3.08M Perf Year 5.52%
Cash/sh - P/C - EPS next 5Y 11.14% ROE 8.55% 52W Range 253.95 - 370.83 Perf YTD 6.08%
Dividend Est. 6.97 (2.19%) P/FCF 11.16 EPS past 5Y 10.54% ROI 5.19% 52W High -14.34% Beta 0.50
Dividend TTM 5.43 (1.71%) Quick Ratio - Sales past 5Y 48.25% Gross Margin - 52W Low 25.09% ATR (14) 7.85
Dividend Ex-Date Sep 04, 2024 Current Ratio 0.83 EPS Y/Y TTM -42.21% Oper. Margin 3.53% RSI (14) 28.75 Volatility 3.53% 2.13%
Employees 72500 Debt/Eq 0.77 Sales Y/Y TTM 16.12% Profit Margin 1.72% Recom 1.46 Target Price 398.64
Option/Short Yes / Yes LT Debt/Eq 0.73 EPS Q/Q 10.82% Payout 28.29% Rel Volume 0.68 Prev Close 317.46
Sales Surprise 3.80% EPS Surprise 4.49% Sales Q/Q 24.40% Earnings Oct 31 BMO Avg Volume 1.33M Price 317.66
SMA20 -7.19% SMA50 -9.06% SMA200 -6.70% Trades
Volume 146,490 Change 0.06%
Date
Action
Analyst
Rating Change
Price Target Change
Jun-26-24 Initiated Piper Sandler
Overweight
$400
May-30-24 Initiated Robert W. Baird
Outperform
$388
Mar-06-24 Initiated Barclays
Overweight
$393
Feb-05-24 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$327 → $354
Feb-05-24 Upgrade Cantor Fitzgerald
Neutral → Overweight
$334 → $372
Feb-01-24 Upgrade Deutsche Bank
Hold → Buy
$355 → $370
Jan-04-24 Upgrade Bernstein
Mkt Perform → Outperform
$330 → $372
Dec-11-23 Upgrade Jefferies
Hold → Buy
$335 → $341
Aug-18-23 Downgrade Edward Jones
Buy → Hold
Jun-06-23 Upgrade BofA Securities
Neutral → Buy
$320
Apr-21-23 Initiated Cantor Fitzgerald
Neutral
$285
Apr-05-23 Upgrade Raymond James
Outperform → Strong Buy
$350
Jan-03-23 Downgrade Wells Fargo
Overweight → Equal Weight
$370 → $355
Nov-23-22 Resumed Morgan Stanley
Overweight
$318 → $347
Nov-21-22 Downgrade Raymond James
Strong Buy → Outperform
$370
Jul-14-22 Downgrade Jefferies
Buy → Hold
$330 → $271
Jun-22-22 Upgrade Morgan Stanley
Equal-Weight → Overweight
$283 → $296
Jun-17-22 Initiated Loop Capital
Hold
$270
May-27-22 Resumed Bernstein
Mkt Perform
$258 → $301
May-26-22 Upgrade BofA Securities
Underperform → Neutral
$265 → $300
Show Previous Ratings
Oct-22-24 07:19PM
Oct-21-24 05:57PM
05:03PM
04:23PM
(The Wall Street Journal)
04:07PM
12:10PM
Loading…
12:10PM
11:18AM
(The Wall Street Journal)
10:44AM
10:40AM
(Investor's Business Daily)
10:27AM
(Life Insurance International)
10:14AM
09:44AM
(Investor's Business Daily)
09:37AM
08:52AM
07:13AM
06:42AM
Loading…
06:42AM
06:00AM
Oct-19-24 04:52PM
04:45PM
Oct-18-24 04:59PM
Oct-14-24 09:40AM
Oct-12-24 07:41AM
Oct-11-24 11:02AM
Oct-10-24 05:39AM
Oct-07-24 07:30AM
05:54AM
Oct-05-24 06:31PM
09:02AM
Oct-04-24 02:36PM
12:10PM
07:09AM
Loading…
07:09AM
06:33AM
Oct-03-24 03:27PM
09:00AM
Oct-02-24 01:09PM
(The Wall Street Journal)
07:13AM
Oct-01-24 08:04AM
06:00AM
Sep-28-24 01:21PM
Sep-26-24 11:46AM
10:21AM
10:10AM
09:40AM
Sep-25-24 01:42PM
Sep-24-24 03:45PM
05:50AM
Sep-20-24 05:20PM
04:54PM
04:54PM
04:17PM
04:06PM
(The Wall Street Journal)
03:27PM
(Associated Press Finance)
03:26PM
02:16PM
10:17AM
05:25AM
Sep-18-24 11:45AM
Sep-17-24 05:07PM
12:54PM
(Pharmaceutical Technology)
11:57AM
11:29AM
07:15AM
07:13AM
(The Wall Street Journal)
04:23AM
Sep-12-24 09:00AM
07:00AM
04:58AM
Sep-11-24 05:07AM
Sep-10-24 09:40AM
Sep-09-24 07:00AM
Sep-05-24 12:56PM
06:00AM
Aug-29-24 02:45PM
(Investor's Business Daily)
06:31AM
Aug-28-24 06:49PM
Aug-25-24 04:17PM
Aug-23-24 09:27PM
Aug-22-24 09:50AM
Aug-15-24 10:09AM
09:00AM
Aug-12-24 07:00AM
Aug-07-24 05:31PM
Aug-05-24 07:00AM
Aug-02-24 03:55AM
(Thomson Reuters StreetEvents)
01:01AM
Aug-01-24 04:07PM
02:07PM
12:03PM
11:48AM
(The Wall Street Journal)
11:15AM
09:30AM
07:10AM
06:19AM
06:07AM
(Associated Press Finance)
06:03AM
06:00AM
Jul-31-24 05:42PM
09:45AM
Jul-30-24 12:47PM
Jul-29-24 09:16AM
The Cigna Group is a global health company, which engages in the provision of global health services. It operates through the following segments: Evernorth Health Services, Cigna Healthcare, Other Operations, and Corporate. The Evernorth Health Services segment partners with health plans, employers, governmental organizations, and health care providers to solve challenges in the areas of pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty distribution, and care delivery and management solutions. The Cigna Healthcare segment includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical and coordinated solutions to clients and customers. The Other Operations segment consists of the remainder of business operations, which includes certain ongoing businesses and exited businesses. The Corporate segment refers to net interest expense, certain litigation matters, expense associated with frozen pension plans, charitable contributions, operating severance, certain overhead and enterprise-wide project costs, and eliminations for products and services sold between segments. The company was founded in 1792 and is headquartered in Bloomfield, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DeLaney William J III Director Aug 19 '24 Option Exercise 175.09 2,691 471,177 20,230 Aug 21 05:14 PM DeLaney William J III Director Aug 19 '24 Sale 342.68 2,691 922,152 17,539 Aug 21 05:14 PM DeLaney William J III Director Aug 19 '24 Proposed Sale 342.68 2,691 922,152 Aug 19 11:10 AM Jones Nicole S See Remarks Aug 12 '24 Option Exercise 149.13 15,030 2,241,499 46,617 Aug 14 04:30 PM Jones Nicole S See Remarks Aug 13 '24 Option Exercise 149.13 2,636 393,120 27,223 Aug 14 04:30 PM Jones Nicole S See Remarks Aug 12 '24 Sale 330.96 22,030 7,291,049 24,587 Aug 14 04:30 PM Triplett Michael W Special Advisor Aug 12 '24 Option Exercise 149.13 7,200 1,073,772 39,652 Aug 14 04:30 PM Triplett Michael W Special Advisor Aug 12 '24 Sale 329.94 6,819 2,249,851 32,833 Aug 14 04:30 PM Jones Nicole S Officer Aug 12 '24 Proposed Sale 330.96 22,030 7,291,049 Aug 12 12:51 PM Triplett Michael W Officer Aug 12 '24 Proposed Sale 329.94 6,819 2,249,850 Aug 12 09:58 AM Evanko Brian C See Remarks Jun 24 '24 Option Exercise 120.89 4,795 579,692 44,718 Jun 26 05:07 PM Evanko Brian C See Remarks Jun 25 '24 Option Exercise 120.89 1,011 122,225 40,934 Jun 26 05:07 PM Evanko Brian C See Remarks Jun 24 '24 Sale 345.01 4,795 1,654,303 39,923 Jun 26 05:07 PM Granger Elder Director Jun 17 '24 Option Exercise 175.09 547 95,776 6,018 Jun 20 06:01 AM Granger Elder Director Jun 17 '24 Sale 331.38 547 181,265 5,471 Jun 20 06:01 AM Granger Elder Director Jun 12 '24 Option Exercise 175.09 1,000 175,094 6,471 Jun 13 05:35 PM Granger Elder Director Jun 12 '24 Sale 338.08 1,000 338,080 5,471 Jun 13 05:35 PM Eder Noelle K See Remarks May 14 '24 Option Exercise 171.38 5,533 948,273 26,524 May 16 05:22 PM Eder Noelle K See Remarks May 15 '24 Option Exercise 171.38 875 149,962 16,699 May 16 05:22 PM Eder Noelle K See Remarks May 14 '24 Sale 348.47 10,700 3,728,629 15,824 May 16 05:22 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer May 14 '24 Option Exercise 120.89 5,946 718,842 8,541 May 16 05:22 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer May 14 '24 Sale 348.71 5,946 2,073,449 2,595 May 16 05:22 PM Cordani David Chairman & CEO Mar 26 '24 Option Exercise 139.22 7,761 1,080,486 355,815 Mar 28 05:14 PM Cordani David Chairman & CEO Mar 25 '24 Option Exercise 139.22 31,209 4,344,917 379,263 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Option Exercise 139.22 6,338 882,376 354,392 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Option Exercise 139.22 2,293 319,231 350,347 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 25 '24 Sale 355.17 31,209 11,084,357 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 22 '24 Sale 355.11 6,338 2,250,682 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 21 '24 Sale 355.02 2,293 814,052 348,054 Mar 25 06:19 PM Cordani David Chairman & CEO Mar 13 '24 Option Exercise 139.22 13,761 1,915,806 354,199 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 14 '24 Option Exercise 139.22 7,616 1,060,300 348,054 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Option Exercise 139.22 2,238 311,574 342,676 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 13 '24 Sale 347.33 13,761 4,779,542 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 12 '24 Sale 345.00 2,238 772,121 340,438 Mar 14 06:09 PM Cordani David Chairman & CEO Mar 08 '24 Option Exercise 139.22 2,801 389,955 343,239 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Option Exercise 139.22 2,412 335,799 342,850 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 08 '24 Sale 345.19 2,801 966,883 340,438 Mar 11 05:38 PM Cordani David Chairman & CEO Mar 07 '24 Sale 345.73 2,412 833,892 340,438 Mar 11 05:38 PM Jones Nicole S See Remarks Mar 04 '24 Sale 332.62 4,436 1,475,502 31,587 Mar 05 05:43 PM Cordani David Chairman & CEO Mar 04 '24 Sale 332.62 19,288 6,415,575 340,438 Mar 05 05:43 PM Triplett Michael W Special Advisor Mar 04 '24 Sale 332.62 1,953 649,607 32,452 Mar 05 05:43 PM Cordani David Chairman & CEO Feb 26 '24 Option Exercise 139.22 10,453 1,455,267 347,236 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Option Exercise 139.22 6,319 879,731 343,102 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 27 '24 Option Exercise 139.22 2,000 278,440 338,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 26 '24 Sale 345.70 10,453 3,613,652 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 23 '24 Sale 345.24 6,319 2,181,592 336,783 Feb 27 05:48 PM Cordani David Chairman & CEO Feb 27 '24 Sale 345.04 2,000 690,075 336,783 Feb 27 05:48 PM Palmer Eric P See Remarks Feb 13 '24 Option Exercise 149.13 5,168 770,730 50,732 Feb 15 05:30 PM Palmer Eric P See Remarks Feb 14 '24 Option Exercise 149.13 905 134,967 45,554 Feb 15 05:30 PM Palmer Eric P See Remarks Feb 13 '24 Sale 340.00 6,083 2,068,220 44,649 Feb 15 05:30 PM Palmer Eric P See Remarks Feb 09 '24 Sale 335.26 1,017 340,956 45,564 Feb 13 05:28 PM Cordani David Chairman & CEO Feb 09 '24 Option Exercise 139.22 38,065 5,299,409 367,386 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 13 '24 Option Exercise 139.22 7,462 1,038,860 336,783 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 12 '24 Option Exercise 139.22 2,073 288,603 331,394 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 09 '24 Sale 335.22 38,065 12,760,123 329,321 Feb 13 05:27 PM Cordani David Chairman & CEO Feb 12 '24 Sale 336.81 2,073 698,198 329,321 Feb 13 05:27 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Option Exercise 78.03 4,867 379,796 6,969 Feb 09 05:04 PM Agoglia Hoeltzel Mary T SVP Tax & Chief Acct. Officer Feb 07 '24 Sale 330.48 4,867 1,608,446 2,102 Feb 09 05:04 PM Palmer Eric P See Remarks Feb 02 '24 Option Exercise 139.22 5,684 791,326 51,248 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 05 '24 Option Exercise 139.22 1,017 141,587 46,581 Feb 06 09:02 PM Palmer Eric P See Remarks Feb 02 '24 Sale 325.00 5,684 1,847,300 45,564 Feb 06 09:02 PM
Index S&P 500 P/E 15.62 EPS (ttm) 18.26 Insider Own 1.12% Shs Outstand 58.00M Perf Week -13.81%
Market Cap 16.72B Forward P/E 10.74 EPS next Y 26.57 Insider Trans -2.52% Shs Float 57.95M Perf Month -17.61%
Income 1.06B PEG 1.39 EPS next Q 5.94 Inst Own 101.55% Short Float 1.97% Perf Quarter -11.99%
Sales 37.39B P/S 0.45 EPS this Y 12.60% Inst Trans 2.95% Short Ratio 1.88 Perf Half Y -22.35%
Book/sh 82.08 P/B 3.48 EPS next Y 13.01% ROA 7.37% Short Interest 1.14M Perf Year -17.22%
Cash/sh - P/C - EPS next 5Y 11.26% ROE 25.12% 52W Range 282.19 - 423.92 Perf YTD -21.04%
Dividend Est. - P/FCF 93.40 EPS past 5Y 12.22% ROI 14.71% 52W High -32.70% Beta 0.57
Dividend TTM - Quick Ratio - Sales past 5Y 13.87% Gross Margin - 52W Low 1.10% ATR (14) 9.44
Dividend Ex-Date - Current Ratio 1.57 EPS Y/Y TTM 15.39% Oper. Margin 4.05% RSI (14) 29.33 Volatility 2.56% 2.20%
Employees 18000 Debt/Eq 0.49 Sales Y/Y TTM 14.59% Profit Margin 2.84% Recom 2.38 Target Price 372.36
Option/Short Yes / Yes LT Debt/Eq 0.49 EPS Q/Q -3.09% Payout 0.00% Rel Volume 2.18 Prev Close 283.96
Sales Surprise 1.37% EPS Surprise 5.33% Sales Q/Q 18.40% Earnings Oct 23 AMC Avg Volume 608.01K Price 285.30
SMA20 -11.20% SMA50 -15.14% SMA200 -18.09% Trades
Volume 214,394 Change 0.47%
Date
Action
Analyst
Rating Change
Price Target Change
May-30-24 Initiated Robert W. Baird
Outperform
$405
Mar-28-24 Downgrade BofA Securities
Neutral → Underperform
$439
Mar-06-24 Initiated Barclays
Equal Weight
$437
Feb-15-24 Upgrade Wells Fargo
Underweight → Equal Weight
$367 → $420
Jun-20-23 Initiated UBS
Neutral
$310
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$354
Dec-13-22 Upgrade BofA Securities
Underperform → Neutral
$388
Oct-03-22 Resumed JP Morgan
Overweight
$360
Jun-17-22 Initiated Loop Capital
Hold
$310
May-26-22 Downgrade BofA Securities
Buy → Underperform
$355 → $335
Dec-14-21 Initiated Goldman
Buy
$335
Nov-22-21 Resumed Deutsche Bank
Hold
$304
Sep-10-21 Initiated Cowen
Outperform
$336
Jul-09-21 Initiated Seaport Global Securities
Neutral
May-19-21 Initiated Wells Fargo
Underweight
$253
Mar-30-21 Initiated Credit Suisse
Outperform
$260
Mar-10-21 Initiated Mizuho
Buy
$245
Feb-19-21 Resumed Barclays
Overweight
$260
Jan-21-21 Initiated Goldman
Neutral
$217
Sep-22-20 Downgrade Stephens
Overweight → Equal-Weight
Show Previous Ratings
Today 09:01AM
Oct-22-24 09:01AM
Oct-21-24 08:32AM
Oct-20-24 04:26PM
Oct-19-24 07:00AM
(The Wall Street Journal)
11:39AM
Loading…
Oct-18-24 11:39AM
Oct-17-24 05:10PM
03:04PM
(The Wall Street Journal)
Oct-16-24 10:01AM
09:00AM
Oct-12-24 07:41AM
Oct-11-24 05:30AM
(The Wall Street Journal)
Oct-01-24 07:58AM
Sep-27-24 04:55AM
Sep-25-24 01:26PM
09:00AM
Loading…
Sep-09-24 09:00AM
Sep-04-24 05:00PM
02:54PM
09:00AM
Aug-26-24 09:46AM
Aug-23-24 11:31AM
Aug-21-24 05:50AM
Aug-20-24 09:00AM
Aug-19-24 01:18PM
Aug-14-24 07:09PM
Jul-26-24 03:58AM
02:10AM
(Thomson Reuters StreetEvents)
01:04AM
Jul-25-24 05:05PM
12:01PM
11:08AM
Loading…
11:08AM
07:00AM
(The Wall Street Journal)
03:06AM
Jul-24-24 04:24PM
(Associated Press Finance)
04:15PM
12:11PM
Jul-23-24 09:00AM
Jul-22-24 09:32AM
Jul-19-24 09:00AM
Jul-18-24 03:36PM
Jul-17-24 10:01AM
09:00AM
(The Wall Street Journal)
Jul-16-24 05:06PM
Jun-05-24 09:00AM
May-29-24 04:31PM
02:00PM
(The Wall Street Journal)
May-24-24 11:31AM
May-22-24 04:15PM
May-16-24 05:36AM
Apr-30-24 01:22PM
06:39AM
Apr-29-24 09:13AM
Apr-26-24 11:37AM
07:51AM
01:08AM
Apr-25-24 02:27PM
Apr-24-24 05:53PM
05:52PM
04:58PM
04:28PM
(Associated Press Finance)
04:15PM
Apr-22-24 09:16AM
Apr-19-24 07:28AM
Apr-16-24 08:30AM
(Investor's Business Daily)
Apr-15-24 04:17PM
12:20PM
09:34AM
(Investor's Business Daily)
Apr-12-24 12:37PM
Apr-11-24 04:30PM
Apr-09-24 12:47PM
Mar-19-24 11:39AM
Mar-08-24 11:30AM
Mar-06-24 09:00AM
Mar-01-24 04:07AM
Feb-29-24 04:15PM
Feb-20-24 11:44PM
Feb-17-24 09:38AM
Feb-15-24 03:03AM
Feb-09-24 08:36AM
12:10AM
(Thomson Reuters StreetEvents)
Feb-08-24 12:43PM
09:40AM
06:33AM
Feb-07-24 07:09PM
06:42PM
04:36PM
04:34PM
(Associated Press Finance)
04:15PM
Feb-02-24 12:51PM
Jan-18-24 09:15AM
Jan-16-24 11:52AM
Jan-12-24 09:58AM
Jan-04-24 09:00AM
Jan-02-24 04:05PM
Dec-19-23 10:27AM
Dec-18-23 08:15AM
Dec-15-23 09:45AM
Dec-06-23 09:18PM
Nov-30-23 09:40AM
Nov-28-23 12:20PM
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
HEBERT MAURICE Chief Accounting Officer Aug 15 '24 Sale 346.52 393 136,182 9,473 Aug 16 04:53 PM HEBERT MAURICE Officer Aug 15 '24 Proposed Sale 346.52 393 136,182 Aug 15 05:35 PM ORLANDO STEVEN J Director Jul 30 '24 Sale 339.21 1,000 339,210 18,025 Jul 30 04:46 PM Barlow Jeff D. Chief Legal Officer Jul 29 '24 Sale 335.00 5,340 1,788,900 66,148 Jul 30 04:45 PM Barlow Jeff D. Officer Jul 29 '24 Proposed Sale 335.00 5,340 1,788,900 Jul 29 05:48 PM ORLANDO STEVEN J Director Jul 30 '24 Proposed Sale 333.00 1,000 333,000 Jul 29 04:24 PM WOYS JAMES Chief Operating Officer May 22 '24 Sale 345.15 10,000 3,451,480 53,613 May 24 05:34 PM ROMNEY RONNA Director May 21 '24 Sale 343.27 250 85,818 16,945 May 22 04:59 PM Schapiro Richard M Director Feb 20 '24 Sale 401.05 1,000 401,050 11,207 Feb 20 04:56 PM ORLANDO STEVEN J Director Feb 15 '24 Sale 399.12 750 299,340 18,701 Feb 16 04:48 PM WOLF DALE B Director Feb 15 '24 Sale 398.38 1,500 597,570 14,867 Feb 16 04:46 PM Bacon Debra EVP, Medicaid Feb 14 '24 Sale 396.22 500 198,110 4,573 Feb 16 04:45 PM Keim Mark Lowell Chief Financial Officer Feb 12 '24 Sale 386.56 15,000 5,798,455 36,531 Feb 14 04:38 PM Schapiro Richard M Director Feb 12 '24 Sale 384.06 711 273,068 12,207 Feb 14 04:35 PM ROMNEY RONNA Director Nov 29 '23 Sale 358.00 335 119,929 16,907 Nov 29 07:44 PM ORLANDO STEVEN J Director Oct 30 '23 Sale 325.96 1,134 369,639 19,299 Oct 31 06:48 PM
Index - P/E - EPS (ttm) -0.26 Insider Own 25.14% Shs Outstand 393.27M Perf Week -10.56%
Market Cap 1.90B Forward P/E - EPS next Y -0.15 Insider Trans 1.16% Shs Float 372.43M Perf Month 28.72%
Income -123.70M PEG - EPS next Q -0.04 Inst Own 14.83% Short Float 6.85% Perf Quarter 132.32%
Sales 1.69B P/S 1.12 EPS this Y 68.85% Inst Trans -18.40% Short Ratio 2.79 Perf Half Y 486.15%
Book/sh 0.67 P/B 5.65 EPS next Y -6.15% ROA -13.24% Short Interest 25.51M Perf Year 312.74%
Cash/sh - P/C - EPS next 5Y 19.10% ROE -39.04% 52W Range 0.61 - 4.71 Perf YTD 300.17%
Dividend Est. - P/FCF - EPS past 5Y -585.84% ROI -37.78% 52W High -19.11% Beta 2.15
Dividend TTM - Quick Ratio - Sales past 5Y 52.25% Gross Margin - 52W Low 528.71% ATR (14) 0.28
Dividend Ex-Date - Current Ratio 1.69 EPS Y/Y TTM 52.91% Oper. Margin -6.38% RSI (14) 55.86 Volatility 8.20% 8.57%
Employees 552 Debt/Eq 0.01 Sales Y/Y TTM -39.55% Profit Margin -7.32% Recom 2.33 Target Price 3.07
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 125.29% Payout - Rel Volume 0.91 Prev Close 3.94
Sales Surprise 5.16% EPS Surprise 120.62% Sales Q/Q -30.64% Earnings Aug 05 AMC Avg Volume 9.14M Price 3.81
SMA20 1.87% SMA50 17.45% SMA200 138.09% Trades
Volume 1,353,429 Change -3.30%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-07-24 Initiated UBS
Neutral
$4
Feb-02-22 Upgrade Cowen
Underperform → Market Perform
$7 → $3
Feb-02-22 Initiated Canaccord Genuity
Buy
$6
Jan-19-22 Initiated SVB Leerink
Mkt Perform
$3
Jan-10-22 Resumed Citigroup
Neutral
$9 → $3.50
Jan-07-22 Downgrade Credit Suisse
Neutral → Underperform
$9 → $3.50
Sep-10-21 Initiated Cowen
Underperform
$7
Sep-02-21 Resumed Citigroup
Neutral
$10
Jul-12-21 Downgrade JP Morgan
Neutral → Underweight
$9
Jun-10-21 Downgrade BofA Securities
Neutral → Underperform
$10
May-17-21 Downgrade BofA Securities
Buy → Neutral
$15 → $9
Mar-09-21 Initiated Credit Suisse
Neutral
$10
Feb-02-21 Initiated Citigroup
Buy
$19
Feb-01-21 Initiated JP Morgan
Neutral
$15
Show Previous Ratings
Oct-17-24 09:18PM
Oct-15-24 09:15AM
Oct-10-24 05:03PM
Oct-08-24 06:15AM
Sep-26-24 04:00PM
11:54PM
Loading…
Sep-03-24 11:54PM
04:05PM
Sep-02-24 12:17PM
Aug-22-24 09:00AM
Aug-21-24 04:05PM
Aug-13-24 07:05PM
(GuruFocus.com) +6.95%
+25.50%
Aug-05-24 04:05PM
Jul-24-24 04:05PM
Jul-22-24 04:05PM
Jul-07-24 11:53PM
12:32PM
Loading…
12:32PM
Jun-26-24 04:15PM
Jun-21-24 01:36PM
(Yahoo Finance Video) +21.36%
Jun-14-24 09:00AM
May-29-24 08:00AM
May-15-24 06:04AM
May-09-24 01:01AM
May-08-24 12:13PM
07:31AM
May-07-24 11:54PM
04:05PM
11:03AM
May-01-24 04:05PM
Apr-30-24 04:15PM
Apr-23-24 04:05PM
04:05PM
Loading…
Apr-22-24 04:05PM
Apr-04-24 04:30PM
Mar-19-24 09:00AM
Mar-13-24 09:10AM
Mar-12-24 05:33PM
04:05PM
Mar-07-24 04:05PM
Feb-26-24 04:05PM
Feb-16-24 04:30PM
Jan-10-24 08:30AM
06:59AM
Jan-08-24 05:00PM
Dec-21-23 10:54AM
08:00AM
Dec-18-23 04:05PM
Dec-01-23 08:15AM
Nov-07-23 09:00AM
08:35AM
Nov-06-23 04:58PM
04:05PM
Nov-01-23 09:00AM
Oct-17-23 04:30PM
Oct-12-23 08:30AM
Oct-02-23 09:40AM
Sep-22-23 03:05PM
09:00AM
Sep-20-23 04:30PM
Aug-08-23 04:05PM
Aug-03-23 04:15PM
Aug-02-23 04:05PM
Aug-01-23 04:20PM
Jul-11-23 04:05PM
Jun-22-23 04:05PM
May-10-23 11:12AM
May-09-23 04:34PM
May-04-23 04:05PM
Apr-24-23 09:00AM
Apr-17-23 09:00AM
Apr-11-23 04:05PM
Mar-07-23 04:05PM
Feb-28-23 06:30AM
Feb-22-23 04:05PM
Jan-30-23 04:05PM
Jan-10-23 09:15AM
Jan-04-23 04:05PM
(GlobeNewswire) +5.09%
-7.50%
Dec-13-22 04:30PM
Nov-30-22 04:05PM
Nov-07-22 04:05PM
Nov-03-22 04:05PM
Oct-11-22 04:05PM
Oct-10-22 04:05PM
Oct-06-22 04:05PM
Aug-31-22 04:05PM
Aug-22-22 03:56PM
Aug-09-22 01:05PM
(American City Business Journals) -17.94%
Aug-08-22 05:12PM
04:08PM
04:06PM
Aug-03-22 04:05PM
Jul-26-22 04:43PM
04:05PM
Jul-18-22 06:32PM
Jul-14-22 04:05PM
Jul-11-22 04:05PM
Jun-24-22 04:05PM
Jun-06-22 08:27AM
May-25-22 04:05PM
May-22-22 07:04AM
May-12-22 10:34AM
May-10-22 02:30PM
Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Garipalli Vivek Director Aug 09 '24 Buy 1.88 531,700 999,596 1,409,267 Aug 13 04:06 PM Garipalli Vivek Director Jun 17 '24 Buy 1.14 877,567 1,000,426 877,567 Jun 20 04:03 PM Loengard Anna U Director May 16 '24 Buy 0.96 17,085 16,372 15,600 May 20 06:57 PM Loengard Anna U Director May 17 '24 Buy 0.93 10,000 9,300 10,000 May 20 06:57 PM Loengard Anna U Director Mar 14 '24 Buy 0.73 137,000 100,010 538,841 Mar 18 04:30 PM Loengard Anna U Director Mar 14 '24 Buy 0.73 13,625 9,946 15,125 Mar 18 04:30 PM
Index DJIA, S&P 500 P/E 37.02 EPS (ttm) 15.39 Insider Own 0.19% Shs Outstand 924.00M Perf Week -0.26%
Market Cap 526.20B Forward P/E 18.89 EPS next Y 30.16 Insider Trans -0.25% Shs Float 921.63M Perf Month -0.93%
Income 14.32B PEG 3.15 EPS next Q 6.78 Inst Own 89.36% Short Float 0.85% Perf Quarter 1.82%
Sales 392.72B P/S 1.34 EPS this Y 9.94% Inst Trans 1.02% Short Ratio 2.53 Perf Half Y 16.94%
Book/sh 97.02 P/B 5.87 EPS next Y 9.21% ROA 4.93% Short Interest 7.86M Perf Year 9.25%
Cash/sh - P/C - EPS next 5Y 11.76% ROE 16.43% 52W Range 436.38 - 608.63 Perf YTD 8.24%
Dividend Est. 7.90 (1.39%) P/FCF 40.18 EPS past 5Y 14.37% ROI 9.35% 52W High -6.37% Beta 0.59
Dividend TTM 7.96 (1.40%) Quick Ratio - Sales past 5Y 10.25% Gross Margin - 52W Low 30.58% ATR (14) 12.57
Dividend Ex-Date Sep 16, 2024 Current Ratio 0.91 EPS Y/Y TTM -32.55% Oper. Margin 7.90% RSI (14) 44.15 Volatility 2.06% 1.88%
Employees 440000 Debt/Eq 0.87 Sales Y/Y TTM 9.66% Profit Margin 3.65% Recom 1.40 Target Price 624.92
Option/Short Yes / Yes LT Debt/Eq 0.83 EPS Q/Q 4.33% Payout 30.55% Rel Volume 0.69 Prev Close 569.86
Sales Surprise 1.70% EPS Surprise 2.07% Sales Q/Q 10.35% Earnings Oct 15 BMO Avg Volume 3.11M Price 569.84
SMA20 -2.03% SMA50 -2.43% SMA200 8.25% Trades
Volume 346,477 Change -0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-24 Downgrade HSBC Securities
Buy → Hold
Oct-11-24 Initiated KeyBanc Capital Markets
Overweight
$675
Jul-17-24 Upgrade Jefferies
Hold → Buy
$481 → $647
Jul-17-24 Reiterated RBC Capital Mkts
Outperform
$555 → $615
Jun-05-24 Upgrade HSBC Securities
Hold → Buy
$580
May-30-24 Initiated Robert W. Baird
Outperform
$597
Apr-04-24 Upgrade HSBC Securities
Reduce → Hold
$460
Mar-06-24 Initiated Barclays
Overweight
$551
Dec-18-23 Downgrade HSBC Securities
Hold → Reduce
$550 → $480
Oct-16-23 Upgrade UBS
Neutral → Buy
$520 → $640
Sep-06-23 Initiated HSBC Securities
Hold
$540
Jul-19-23 Reiterated UBS
Neutral
$510 → $520
Jul-18-23 Upgrade Bernstein
Mkt Perform → Outperform
$595 → $603
Jul-17-23 Reiterated TD Cowen
Outperform
$562 → $555
Jul-17-23 Reiterated RBC Capital Mkts
Outperform
$592 → $572
Jul-17-23 Reiterated JP Morgan
Overweight
$527 → $532
May-26-23 Initiated Piper Sandler
Overweight
$580
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$591
Apr-05-23 Upgrade Raymond James
Outperform → Strong Buy
$615 → $630
Nov-23-22 Resumed Morgan Stanley
Overweight
$587
Show Previous Ratings
Oct-21-24 11:18AM
(The Wall Street Journal)
08:00AM
08:00AM
06:42AM
04:08AM
07:00AM
Loading…
Oct-19-24 07:00AM
(The Wall Street Journal)
Oct-18-24 03:25PM
06:51AM
Oct-17-24 03:04PM
(The Wall Street Journal)
07:20AM
Oct-16-24 09:30AM
03:01AM
Oct-15-24 11:16PM
(Thomson Reuters StreetEvents) -8.11%
07:46PM
04:24PM
04:10PM
Loading…
04:10PM
04:06PM
04:06PM
03:29PM
02:54PM
(The Wall Street Journal)
02:48PM
02:45PM
01:04PM
12:55PM
12:46PM
12:45PM
11:32AM
(The Wall Street Journal)
11:24AM
11:08AM
11:07AM
(The Wall Street Journal)
10:46AM
Loading…
10:46AM
10:27AM
(The Wall Street Journal)
09:48AM
09:30AM
07:36AM
07:17AM
07:05AM
06:04AM
06:04AM
06:04AM
06:02AM
(Associated Press Finance)
05:55AM
Oct-14-24 05:15PM
04:44PM
08:00AM
05:47AM
Oct-13-24 06:00AM
Oct-12-24 10:15AM
09:36AM
07:41AM
Oct-11-24 05:33PM
04:57PM
12:07PM
10:14AM
08:47AM
Oct-10-24 07:02PM
09:15AM
05:39AM
Oct-09-24 04:52PM
10:55AM
10:45AM
Oct-08-24 02:08PM
Oct-07-24 05:50PM
Oct-06-24 08:30AM
Oct-05-24 04:45AM
Oct-04-24 01:33PM
06:59AM
Oct-03-24 11:00AM
10:00AM
09:00AM
Oct-02-24 01:09PM
(The Wall Street Journal)
05:30AM
(The Wall Street Journal)
Oct-01-24 02:13PM
Sep-30-24 05:50PM
12:20PM
09:30AM
09:12AM
08:00AM
04:49AM
04:12AM
Sep-29-24 07:00AM
Sep-27-24 02:06PM
Sep-26-24 10:22AM
03:12AM
Sep-25-24 01:55PM
Sep-24-24 03:45PM
05:50AM
Sep-23-24 10:16AM
08:18AM
Sep-20-24 05:20PM
04:54PM
04:54PM
04:06PM
(The Wall Street Journal)
03:26PM
07:45AM
Sep-19-24 05:11PM
09:00AM
07:11AM
06:02AM
Sep-18-24 05:30PM
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Minnetonka, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ROOS THOMAS E Chief Accounting Officer Jul 17 '24 Sale 569.88 2,851 1,624,734 29,501 Jul 19 04:26 PM McSweeney Erin EVP & Chief People Officer Jul 18 '24 Sale 579.03 1,500 868,538 7,785 Jul 19 04:26 PM HEMSLEY STEPHEN J Director Jun 14 '24 Option Exercise 173.22 332,148 57,536,178 858,256 Jun 14 04:51 PM McSweeney Erin EVP & Chief People Officer Mar 08 '24 Sale 483.48 1,236 597,582 9,364 Mar 12 04:16 PM ROOS THOMAS E Chief Accounting Officer Feb 23 '24 Sale 525.79 858 451,128 32,289 Feb 26 04:25 PM THOMPSON BRIAN R CEO, UnitedHealthcare Feb 16 '24 Option Exercise 255.22 82,348 21,016,460 72,806 Feb 20 04:10 PM THOMPSON BRIAN R CEO, UnitedHealthcare Feb 16 '24 Sale 521.00 28,943 15,079,303 25,543 Feb 20 04:10 PM HEMSLEY STEPHEN J Director Dec 05 '23 Option Exercise 108.97 66,081 7,200,847 701,609 Dec 07 04:22 PM HEMSLEY STEPHEN J Director Dec 05 '23 Sale 550.39 66,081 36,370,196 635,528 Dec 07 04:22 PM
Index S&P 500 P/E 11.55 EPS (ttm) 5.27 Insider Own 1.06% Shs Outstand 534.48M Perf Week -12.15%
Market Cap 32.02B Forward P/E 8.26 EPS next Y 7.37 Insider Trans -0.16% Shs Float 520.45M Perf Month -18.17%
Income 2.82B PEG 1.70 EPS next Q 1.41 Inst Own 98.95% Short Float 1.50% Perf Quarter -9.68%
Sales 157.75B P/S 0.20 EPS this Y 2.05% Inst Trans -0.09% Short Ratio 1.77 Perf Half Y -20.10%
Book/sh 52.00 P/B 1.17 EPS next Y 8.08% ROA 3.40% Short Interest 7.80M Perf Year -14.09%
Cash/sh - P/C - EPS next 5Y 6.80% ROE 10.65% 52W Range 60.65 - 81.42 Perf YTD -17.96%
Dividend Est. - P/FCF 14.16 EPS past 5Y 17.00% ROI 6.29% 52W High -25.22% Beta 0.47
Dividend TTM - Quick Ratio - Sales past 5Y 21.54% Gross Margin - 52W Low 0.38% ATR (14) 1.81
Dividend Ex-Date - Current Ratio 1.17 EPS Y/Y TTM 8.32% Oper. Margin 2.27% RSI (14) 21.94 Volatility 2.02% 1.91%
Employees 76000 Debt/Eq 0.64 Sales Y/Y TTM 6.64% Profit Margin 1.79% Recom 2.10 Target Price 86.00
Option/Short Yes / Yes LT Debt/Eq 0.64 EPS Q/Q 12.31% Payout 0.00% Rel Volume 0.77 Prev Close 61.06
Sales Surprise 8.17% EPS Surprise 14.30% Sales Q/Q 5.92% Earnings Oct 25 BMO Avg Volume 4.40M Price 60.88
SMA20 -12.54% SMA50 -17.15% SMA200 -17.55% Trades
Volume 545,982 Change -0.30%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-24-24 Downgrade Jefferies
Buy → Hold
$83 → $69
May-30-24 Initiated Robert W. Baird
Neutral
$83
Mar-21-24 Downgrade Stephens
Overweight → Equal-Weight
$92 → $85
Mar-06-24 Initiated Barclays
Overweight
$101
Jan-02-24 Upgrade Wells Fargo
Equal Weight → Overweight
$82 → $90
Sep-05-23 Upgrade BofA Securities
Underperform → Neutral
$79 → $72
Aug-30-23 Downgrade Morgan Stanley
Overweight → Equal-Weight
$94 → $73
Jul-12-23 Downgrade Wolfe Research
Outperform → Peer Perform
Jun-20-23 Initiated UBS
Neutral
$72
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$80
Mar-08-23 Downgrade Deutsche Bank
Buy → Hold
$94 → $79
Feb-23-23 Downgrade JP Morgan
Overweight → Neutral
$94 → $90
Dec-13-22 Downgrade BofA Securities
Neutral → Underperform
$100 → $85
Sep-30-22 Initiated Argus
Buy
$90
Aug-26-22 Downgrade Wells Fargo
Overweight → Equal Weight
$103 → $99
Jul-28-22 Resumed Barclays
Overweight
$107
Jul-14-22 Upgrade Jefferies
Hold → Buy
$82 → $115
Jun-21-22 Upgrade Credit Suisse
Neutral → Outperform
$86 → $88
Jun-17-22 Initiated Loop Capital
Buy
$100
May-27-22 Resumed Bernstein
Outperform
$111 → $108
Show Previous Ratings
Oct-22-24 09:15AM
Oct-21-24 06:58PM
Oct-19-24 07:00AM
(The Wall Street Journal)
Oct-18-24 10:00AM
Oct-17-24 05:10PM
03:04PM
Loading…
03:04PM
(The Wall Street Journal)
08:00AM
Oct-15-24 10:07AM
07:00AM
Oct-14-24 02:56PM
Oct-12-24 07:41AM
Oct-11-24 05:30AM
(The Wall Street Journal)
Oct-09-24 06:29AM
Oct-08-24 08:30AM
Oct-07-24 08:00AM
08:00AM
Loading…
Oct-02-24 08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
Loading…
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
08:00AM
Oct-01-24 08:00AM
Sep-25-24 01:30PM
Sep-24-24 12:41PM
Sep-23-24 02:00PM
Sep-19-24 09:00AM
Sep-13-24 05:26AM
Sep-12-24 04:21PM
11:24AM
10:30AM
Sep-11-24 04:15PM
Sep-10-24 07:18AM
Sep-05-24 12:55PM
09:40AM
05:29AM
Sep-04-24 05:00PM
03:44PM
02:54PM
12:35PM
10:44AM
Aug-29-24 04:15PM
Aug-28-24 05:49PM
11:00AM
Aug-19-24 09:40AM
Aug-15-24 04:15PM
10:09AM
Aug-13-24 09:00AM
Aug-09-24 06:37PM
Aug-08-24 11:00AM
Aug-01-24 09:00AM
Jul-31-24 03:46PM
11:00AM
07:00AM
Jul-30-24 01:22PM
Jul-29-24 03:11AM
Jul-27-24 02:51AM
(Thomson Reuters StreetEvents)
01:06AM
Jul-26-24 10:19PM
01:36PM
12:49PM
11:45AM
11:07AM
09:30AM
07:10AM
06:10AM
(Associated Press Finance)
06:05AM
06:00AM
05:15AM
Jul-25-24 08:00AM
07:00AM
(The Wall Street Journal)
Jul-23-24 01:39PM
09:15AM
Jul-22-24 02:06PM
Jul-19-24 10:00AM
Jul-18-24 12:59PM
11:00AM
10:53AM
Jul-17-24 09:00AM
(The Wall Street Journal)
07:20AM
Jul-16-24 10:00AM
09:00AM
Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options' vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COUGHLIN CHRISTOPHER J Director May 14 '24 Sale 76.75 878 67,382 0 May 24 05:28 PM FASOLA KENNETH J President May 13 '24 Sale 77.62 8,000 620,960 300,357 May 15 06:10 PM Robinson Lori Jean Director Feb 13 '24 Option Exercise 54.65 10,000 546,500 21,455 Feb 15 06:31 PM Robinson Lori Jean Director Feb 13 '24 Sale 77.41 10,000 774,100 11,455 Feb 15 06:31 PM FASOLA KENNETH J President Feb 07 '24 Sale 75.07 12,000 900,817 235,365 Feb 08 07:38 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
